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During a 8-month curricular training period the candidate was enrolled at the Faculty of 
Veterinary Medicine (FMV-UTL) – Technical University of Lisbon at the Department of 
Epidemiology & Economics and Veterinary Public Health (01/09/2008 – 28/01/2009), and at 
the Faculty of Life Sciences (LIFE-KU) – University of Copenhagen at the Epidemiology 
Group of the Department of Large Animal Sciences (02/02/2009 – 04/05/2009).  
During all the training period Professor Virgílio da Silva Almeida was the Co-Supervisor. 
 
In the first part of the training period, Dr. Telmo Nunes was assigned as supervisor and the 
training had as main objective the development of scientific skills in epidemiological & risk 
analysis and data management under the topic of Bluetongue Surveillance in Portugal.  
During the FMV-UTL training period several small projects were developed: 
 Project 1: 
o Topic: Bluetongue prevalence estimation in Portugal in 2005 from pre-
movement tests data; 
o Learning objectives: bluetongue disease; bluetongue vectors; epidemiological 
indicators; data management and analysis; data geographical representation; 
 Project 2: 
o Topic: Types of confidence intervals for a proportion; 
o Learning objectives: confidence intervals;  
 Project 3: 
o Topic: Geographical representation of the evolution of Bluetongue virus 
restriction zones between 2004 and 2008 in Portugal; 
o Learning objectives: data geographical representation; data management; 
 Project 4: 
o Topic: Animal and herd densities in Portugal; 
o Learning objectives: data geographical representation; data management; 
Kernel densities; sampling processes; 
 Project 5: 
o Topic: Risk factors for the Culicoides occurrence at herd level in Portugal; 
o Learning objectives: bluetongue risk factors; bluetongue vectors; survey 
design; data management and analysis; epidemiological measures of 
association; 
 Project 6: 
o Topic: Portugal Culicoides occurrence modelling; 
o Learning objectives: bluetongue risk factors; bluetongue vectors; data 
management and analysis; remote sensing; logistic regression models; 
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In order to develop the above mentioned projects, the following software programmes were 
explored: MS Office Access, MS Office Excel, ArcGIS, GvSIG, JMP 7 and SAS. 
 
During the training at FMV-UTL the candidate also participated in: 
 Animal Health Department seminars: 
o Presentation: 
 “Types of confidence intervals for a proportion” by Diogo Marques  
(FMV-UTL) – 21th October 2008, FMV-UTL; 
o Purpose: Overview of the main types of confidence intervals for a proportion 
used in epidemiology; 
o Participants: Telmo Nunes (FMV-UTL), Hugo Martins (FMV-UTL), Solange 
Pacheco (FMV-UTL), Ana Duarte (FMV-UTL); 
 
 Workshops: 
o GIS Workshop: 
 Presentation: 
 “Geographical Information Systems (GIS) applied to 
Epidemiology” by Hugo Martins (FMV-UTL), 13th - 14th October 
2008; 
 Purpose: Introduction to GIS, GvSIG and ArcGIS training; 
 Participants: Solange Pacheco (FMV-UTL), Ana Duarte (FMV-UTL), 
Emanuel Garcia (FMV-UTL), Rui Cepeda (FMV-UTL), Vasco Martins 
(FMV-UTL), André Silva (FMV-UTL), Miguel Figueiredo (FMV-UTL). 
 
o Statistics Workshop: 
 Presentation: “Data analysis and statistical tests” by Filipa Matos 
Baptista (LIFE–KU, FMV-UTL) – 08th - 09th  January 2009, FMV-UTL; 
 Purpose: Statistical methods applied to epidemiology, SAS training; 
 Participants: Virgílio Almeida (FMV-UTL), Telmo Nunes (FMV-UTL), 
Hugo Martins (FMV-UTL), Solange Pacheco (FMV-UTL), Ana Duarte 
(FMV-UTL), Emanuel Garcia (FMV-UTL). 
 
 Conferences and Congresses: 
o “II Technical Journeys – Caçador Pecuária/Batallé/OPP” - Seminar on Swine 
Production – 07th November 2008, Leiria; 
o “IV Congress of Veterinary Sciences Portuguese Society / I Iberian Congress of 




In the second part of the training period the candidate joined the Epidemiology Group 
working on Paratuberculosis at LIFE-KU – Denmark. Professor Søren Saxmose Nielsen was 
his supervisor and the main objective of the training was the assessment of MAP occurrence 
in unprocessed beef and milk.  
 
During the training period two seminars were organized by Søren Saxmose Nielsen:  
 Start-up Seminar: 
o Presentations: 
 “Paratuberculosis” by Søren Saxmose Nielsen (LIFE-KU) – 05th February 
2009, LIFE-KU; 
 “Short overview of Microbial Risk Assessment” by Sara Monteiro Pires 
(Food-DTU) - 05th February 2009, LIFE-KU; 
o Purpose: Discuss the objectives, outline, boundaries and expected results of the 
candidate’s work;  
o Participants: Hans Houe (LIFE-KU), Jens Frederik Agger (LIFE-KU), Liza 
Rosenbaum Nielsen (LIFE-KU), Filipa Matos Baptista (LIFE-KU, FMV-UTL), Lis 
Alban (Danish Meat Association), Heidi Mikkelsen (Vet-DTU) and Antonio Vieira 
(Food-DTU). 
 
 Follow-up Seminar: 
o Presentations: 
 “MAP occurrence in unprocessed beef and milk” by Diogo Marques (FMV-
UTL) – 28th April 2009, LIFE-KU; 
 “Implication of MAP infection on cattle food chain” by Hisako Okura (LIFE-
KU) – 28th April 2009, LIFE-KU; 
o Purpose: Discuss the results of the candidate’s work; Provide Hisako Okura 
inputs to her PhD. study on MAP risk assessment. 
o Participants: Søren Saxmose Nielsen (LIFE-KU), Jens Frederik Agger (LIFE-KU), 
Liza Rosenbaum Nielsen (LIFE-KU), Nils Toft (LIFE-KU), Erik Rattenborg 
(Danish Dairy Board), Heidi Mikkelsen (Vet-DTU), Sara Monteiro Pires (Food-
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Modelo conceptual da avaliação do risco de ocorrência do  
Mycobacterium avium subspécie paratuberculosis em carne e leite de bovino não 
processados 
 
A etiologia da Doença de Crohn é actualmente desconhecida e o Mycobacterium avium 
subspécie paratuberculosis (MAP) tem sido proposto como um dos possíveis agentes 
etiológicos.  
Apesar de não ter sido ainda estabelecida uma relação causal entre a Doença de Crohn e o 
MAP, este tem sido frequentemente isolado em humanos. O consumo de leite e carne é 
considerado um possível veículo do MAP, justificando-se por isso a avaliação do risco de 
ocorrência do MAP nos produtos mencionados.  
Este trabalho teve como objectivo avaliar a probabilidade de ocorrência do MAP em carne e 
leite de bovino, não sujeitos a processamento tecnológico.  
De forma a consultar e avaliar informação existente, foi feita uma pesquisa bibliográfica 
exaustiva sobre a disseminação da infecção por MAP e sobre o isolamento do MAP por 
cultura bacteriológica de tecidos. A principal lacuna identificada foi a ausência de informação 
detalhada sobre: i) o mecanismo de disseminação do MAP e a importância da contaminação 
fecal; ii) a relação entre a disseminação do MAP e outros indicadores (sinais clínicos, lesões 
macroscópicas, resposta imunitária); iii) a prevalência do MAP na carne e no leite nos 
diferentes estadios de infecção.  
A ausência desta informação não permite a avaliação do risco e a consequente definição de 
medidas específicas com vista à sua mitigação. Neste trabalho são descritas as árvores de 
eventos, pressupostos, informação necessária e as lacunas no conhecimento. 
Estudos futuros são necessários para disponibilizar a informação inexistente e para 
desenvolver e aperfeiçoar testes de diagnóstico para detecção directa do MAP na carne e 
no leite de bovino. 
 
Palavras-chave: Mycobacterium avium subspécie paratuberculosis; Infecção disseminada do 









Risk assessment conceptual model of occurrence of  




Crohn’s Disease aetiology is currently unknown and Mycobacterium avium subspecies 
paratuberculosis (MAP) has been proposed as its etiologic agent.  
Despite the absence of a causal relationship between MAP and Crohn’s Disease, MAP has 
been frequently isolated in humans. Milk and beef consumption is considered a possible 
MAP source. Thus the risk of MAP occurrence on these products should be assessed. 
The main objective of this work was to assess the probability of MAP occurrence in 
unprocessed beef and bovine milk. 
In order to assemble the available data, an exhaustive literature search was made on the 
dissemination of MAP infection and MAP isolation by bacteriologic tissue culture. The main 
knowledge gaps found were the lack of detailed information on: i) MAP dissemination 
mechanism and the importance of faecal contamination; ii) relation between MAP 
dissemination and other indicators (clinical signs, gross lesions, immune response); iii) MAP 
prevalence on beef and milk by stage of infection. 
Due to the lack of this information, the risk assessment and the characterization of the risk 
mitigation measures could not be performed. The risk model pathways, its assumptions, data 
required and knowledge gaps are described in this work. 
Further research is needed to make available the mentioned knowledge gaps and to develop 





Keywords: Mycobacterium avium subspecies paratuberculosis; Disseminated MAP infection; 
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1.1 Project objectives 
 
During 3 months, the candidate joined the Epidemiology Group of the Department of Large 
Animal Sciences at the Faculty of Life Sciences – University of Copenhagen. This was 
possible due to a student mobility grant of ERASMUS/SOCRATES programme. 
In the framework of the Danish control programme of bovine paratuberculosis, a start-up 
seminar of MAP occurrence on beef and milk was organized and experts on relevant matters 
were present. During the seminar, the objectives, outline, boundaries and expected results of 
the present dissertation were discussed. 
 
The main objective initially proposed was the assessment of MAP occurrence in 
unprocessed beef and bovine milk. In order to accomplish this objective, an exhaustive 
literature-based search was made to understand the relevant aspects of Paratuberculosis 
and MAP infection, to assess the current knowledge and to identify unavailable inputs 
required to develop the proposed risk assessment. 
 
Due to considerable knowledge gaps it was not possible to accomplish the main objective 
but the available and non-available risk assessment inputs were described and proposals for 
MAP risk assessment model pathways were made. 
 
This dissertation is composed by four parts: 
1. Introduction (objectives and problem definition);  
2. Overview of Paratuberculosis and MAP infection;  
3. Literature revision concerning MAP isolation by tissue culture and MAP distribution on 
tissues;  
4. A proposal of risk assessment model pathways to assess the risk of MAP occurrence 




1.2 Problem definition 
 
1.2.1 Mycobacterium avium subspecies paratuberculosis and Crohn’s Disease 
 
Crohn’s Disease (CD) is a chronic disease that affects the gastro-intestinal tract of humans. 
Usually, it occurs in young adults showing as major symptoms diarrhoea and chronic pain 
(Grant, 2005; Waddell et al., 2008).  
Chiodini, Van Kruiningen, Merkal, Thayer & Coutu (1984) isolated Mycobacterium sp. 
organisms from several patients with CD. This finding revived the idea of a mycobacterial 
cause for this human disease (Chiodini, Van Kruiningen, Merkal, Thayer & Coutu, 1984).  
Since then, Mycobacterium avium subspecies paratuberculosis (MAP) has been isolated 
from several patients and a possible link between CD and MAP has been discussed in the 
last decades. Some of the findings that support this link are: the similarities of clinical signs 
between CD and bovine paratuberculosis (in which MAP is the etiological agent); detection of 
MAP on faeces, intestinal tissues and blood from CD patients; demonstration of a serological 
response to MAP antigens in Crohn’s patients; and anti-MAP antibiotic therapy resulting in 
remission or reduction of clinical signs. Several potential roles of MAP in CD patients have 
been suggested: MAP could be the primary infectious agent of CD; a secondary invader in a 
host with a compromised intestinal barrier; or colonize the intestinal tract without causing any 
harm (Grant, 2005). Because there are inconclusive and contradictory studies, difficulties on 
the isolation of MAP organisms and unexpected results, it is very difficult to achieve a 
consensus between authors (Waddell et al., 2008; Grant, 2005). In a recent systematic 
review, Waddell et al (2008) analyzed many studies and several MAP isolation methods in 
CD patients and concluded that the “evidence of association is not strong, but should not be 
ignored”. Despite the absence of an irrefutable causal relationship between MAP and CD, 
MAP has been consistently isolated in humans and its source should be investigated. Food 
and water-borne sources have been suggested (Grant, 2005).  
 
1.2.2 Human MAP sources - Water 
 
Water as a MAP source has not been properly investigated and its potential as a vehicle of 
transmission of MAP to humans is unknown (reviewed in: Grant, 2005)1. Water containing 
MAP may be consumed directly, incorporated into food, used to wash food products or 
surfaces used to manipulate food. MAP survival characteristics in water environments were 
analyzed by Larsen, Merkal & Vardaman (1956), Lovell, Levi & Francis (1944) and 
Whittington, Marshall, Nicholls, Marsh & Reddacliff (2004). The presence of mycobacteria in 
                                                
1 The connotation “reviewed in” is used to differentiate review from original articles. 
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piped supplies suggests that water standard treatments have little effect on these organisms. 
The chlorination effect was studied in experimentally contaminated water and MAP was not 
completely eliminated by this process (Whan, Grant, Ball, Scott & Rowe, 2001). These 
findings make water a plausible MAP source that should be properly investigated.  
 
1.2.3 Human MAP sources – Beef and Milk 
 
Beef, milk and milk products are food products of bovine origin largely consumed by humans. 
There are no specific regulations about MAP presence on food products. Thus contaminated 
milk and beef may be consumed by humans. 
  
MAP occurrence on milk and milk products was studied by several authors and through 
different methods (reviewed in: Slana, Paolicchi, Janstova, Navratilova & Pavlik, 2008). MAP 
was isolated by culture on milk samples aseptically collected from individual cows (Alexejeff-
Goloff, 1929; Streeter, Hoffsis, Bechnielsen, Shulaw & Rings, 1995; Sweeney, Whitlock & 
Rosenberger, 1992a; Taylor, Wilks & McQueen, 1981; Paolicchi et al., 2003; Ayele, 
Svastova, Roubal, Bartos & Pavlik, 2005; Pillai & Jayarao, 2002; Giese & Ahrens, 2000; 
Jayarao et al., 2004). MAP was also identified on milk and milk products after industrial 
processing steps and their effect on MAP survival or mitigation was discussed (Slana et al., 
2008; reviewed in: Grant, 2006). However, MAP resistance to milk industrial processing 
steps is not broadly accepted due to contradictory results and some study designs were 
criticized. Differences between the laboratory techniques used and industrial procedures are 
the reasons suggested for these differences, e.g. initial MAP concentrations; MAP origin - 
culture collection/field strains; absence/presence of turbulent flow during heating to assure 
that all milk particles get the same treatment; heating methods, volumes of milk tested; and 
absence/presence of homogenization step (reviewed in: Grant, 2006; Rademaker, Vissers & 
Giffel, 2007).  
Presence of MAP after various processing procedures is not fully understood. It may be 
attributable to its high heat resistance (e.g. cell clumping, phagocytosis) (Rademaker et al., 
2007) or to contamination during the process. It can be due to cross contamination during 
laboratory analysis; leaks on the heat exchanger plates of pasteurization plants enabling raw 
milk to contaminate pasteurized milk; and use of pasteurizers during a long time between 
cleaning processes (milk dry matter deposits leading to decrease in heat treatment efficacy) 
(Cerf, Griffiths & Aziza, 2007).  
Map isolation and quantification constrains are also encountered in the evaluation of milk 
processing steps. The real number of MAP present in raw or pasteurized milk cannot be 
precisely estimated because milk culture requires a chemical decontamination treatment 
which has adverse effects on MAP viability (Dundee, Grant, Ball & Rowe, 2001; Grant & 
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Rowe, 2004) ending on an underestimation of MAP numbers (Grant, Williams, Rowe & Muir, 
2005). The dilution on bulk milk tank also influences the detection of MAP on raw and 
processed milk. Despite the lack of consensus on the effect of milk processing steps on 
MAP, the evidence of MAP occurrence on retailed milk makes this product a key MAP 
source to be investigated. 
 
Regarding beef, little information is available about this possible source of MAP to 
consumers. MAP was isolated by culture from muscle tissue (Antognoli et al., 2008; Alonso-
Hearn et al., 2009), MAP DNA was obtained from surface swabs collected from beef 
carcasses at the slaughterhouse after skinning and dressing (Meadus, Gill, Duff, Badoni & 
Saucier, 2008), and two MAP detection methods in ground beef were compared (Jaravata, 
Smith, Rensen, Ruzante & Cullor, 2007).  
MAP organisms may be reduced or eliminated by heating during cooking procedures. 
However, the effect of heating processes on MAP survival in the muscle matrix has not been 
evaluated (Alonso-Hearn et al., 2009). Raw and undercooked meat consumption should also 
be considered. Some products such as sausages and minced meat are based on low quality 
meat, resulting in a larger probability of coming from infected cattle with high MAP 
contamination rates (Alonso-Hearn et al., 2009). Beef as MAP food source to consumers 
should be subjected to further research. 
 
1.2.4 Map occurrence on products entering the food chain and the support of the risk 
assessment 
 
Considering these three MAP sources to humans (water, milk and beef), the reason behind 
MAP presence on these products should be assessed.  
Water contamination has been mainly attributed to contamination with faeces of infected 
animals and to MAP capacity to survive for long periods of time on the environment 
(reviewed in: Grant, 2005).  
MAP isolation from milk, muscle and other tissues, for example non gastro-intestinal lymph 
nodes and internal organs led some authors to suggest the possibility of MAP dissemination 
inside the infected host (Alonso-Hearn et al., 2009; Antognoli et al., 2008; Dennis et al., 
2008; Hines, Buergelt, Wilson & Bliss, 1987; Pavlik et al., 2000). Yet there is also the chance 
of contamination by MAP of faecal origin during tissue collection and/or food processing. 
The view of MAP entry into the food chain, its potential to survive along food processing, the 
lack of MAP regulations, the increased claim of food safety by consumers, the continuous 
search for better and more competitive products by the dairy and meat industries, and the 
commitment to promote Public Health by the veterinary authorities, made this mycobacteria a 
subject of study. In order to properly address the MAP source to humans, a MAP risk 
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assessment on the food chain would be of great importance for risk managers to take better 
and more cost-effective decisions. 
This work will therefore contribute to the development of such assessment in the most 
important products of animal origin, beef and milk. Water as a MAP source was excluded 
regarding the amount of knowledge gaps and the lack of published studies. Therefore, and 
due to time limitations, animal products consumed by humans were given priority. 
The assessment of MAP occurrence in beef and milk will be addressed as a qualitative risk 
assessment and will be limited to a release assessment, i.e. the final objective will be to 
evaluate the probability and the quantity of MAP shed by infected animals into specific 
animal products. 
The exposure assessment step was not incorporated in this study because: 
o the causal relationship between MAP and Crohn’s disease has not been 
established; 
o MAP doses that causes an undesirable effect on humans are unknown; 
o there is a lack of consensus about the effect of food processing steps on MAP 
survival/reduction. 
As this dissertation was elaborated in the framework of a curricular training period in 
Denmark, the Danish control programme of bovine paratuberculosis will be used as a model. 
The assessment will be restricted to cattle because of the larger amount of scientific 
publications and the special focus on cattle of the Danish bovine paratuberculosis control 
programme. 
The end-points assumed will be the milk at herd level (individual milk) and the carcass at the 
end of the slaughter line. These end-points are in agreement with the purpose of the release 
assessment. 
This work will focus on MAP dissemination inside the host, rather than on faecal 







Paratuberculosis (ParaTB) is a chronic, infectious disease caused by Mycobacterium avium 
subspecies paratuberculosis (MAP). It is a Gram-positive, intracellular facultative, acid-fast 
bacillus that is slow-growing, and has complex nutritional requirements in culture. It requires 
an organic source of iron and mycobactins to grow in vitro (reviewed in: Chiodini, Van 
Kruiningen & Merkal, 1984). Through genomic DNA analysis it was shown that it has an 
unique insertion sequence: IS900 (Green et al., 1989). The genus Mycobacterium consists of 
about 50 species that are grouped according some similarities. The most known are the 
Mycobacterium tuberculosis complex (including M. tuberculosis and M. bovis), 
Mycobacterium leprae and Mycobacterium avium-intracelullare complex (including 
Mycobacterium avium and MAP) (Buergelt, Bastianello & Michel, 2004; Coetzer & Tustin, 
2004). Cell wall elements of mycobacteria not only help in the survival and resistance of the 
agent against host defences but are also responsible for the host strong immunological 
response (reviewed in: Clarke, 1997). MAP has been shown to survive on the environment at 
different conditions. It can survive not only in dry conditions (Larsen, Merkal & Vardaman, 
1956) but also in freezing environment (Larsen et al., 1956; Richards & Thoen, 1977) or 
water, soil and faeces (Jorgensen, 1977; Larsen et al., 1956; Lovell, Levi & Francis, 1944; 
Whittington, Marshall, Nicholls, Marsh & Reddacliff, 2004). It may stay viable in slurry, even 
when submitted to heat treatments (Olsen, Jorgensen & Nansen, 1985; Jorgensen, 1977) 
and in different water sources (Whittington, Marsh & Reddacliff, 2005). Recent studies 
suggest rather effective survival strategies namely an interaction between MAP, protozoa, 
nematodes and insects (Rowe & Grant, 2006) and the move into a dormancy state when 




Paratuberculosis occurs on several ruminant species but it is most studied on domestic 
ruminants. It is a widespread infection in Europe with cattle within-herd prevalence ≈ 20% 
and between-herd > 50% in cattle herds and > 20% in small ruminants flocks (Nielsen & Toft, 
2009). 
MAP can be transmitted by either direct or indirect contact between infected and susceptible 
animals. Transmission occurs mainly by faecal-oral route. Shedding animals play an 
important role contaminating the feed, water and pastures (reviewed in: Clarke, 1997). 
Transmission can also occur in utero (Doyle, 1958; Sweeney, Whitlock & Rosenberger, 
1992b),  by ingestion of infected colostrum and milk from infected cows or when the teats are 
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contaminated with faeces (Streeter et al., 1995; Sweeney et al., 1992a). Contaminated 
feeding utensils, herd worker’s shoes or clothing, wildlife ruminant reservoirs and certain 
veterinary procedures (e.g. rectal examination) can also transmit MAP (Sweeney, 1996). 
Between-herd transmission is thought to be mostly caused by purchases of healthy carriers. 
However, a break on the herd biosecurity or a direct contamination between herds, for 
example a common water source, may result on a cluster of paratuberculosis cases bearing 
in mind the resistance of MAP in environment (Sweeney, 1996; Whittington et al., 2005). 
The animals that are more vulnerable to infection are the neonates and some studies point to 
the existence of an age-dependent resistance (Bendixen, 1978; Buergelt, Hall, McEntee & 
Duncan, 1978; Larsen, Merkal & Cutlip, 1975; Rankin, 1958; Rankin, 1961b; Rankin, 1961a; 
Rankin, 1962; reviewed in: Windsor & Whittington, 2009). Hypothesis to explain calves’ 
susceptibility are: (i) an age-related difference on cellular immune response (Windsor & 
Whittington, 2009); (ii) effect (dilution or harmful effect) that the functional rumen of adult 
animals may have on MAP before they reach the gut (Windsor & Whittington, 2009); (iii) the 
existence of  an “open gut” in calves that besides allowing some macromolecules such as 
immunoglobulins from colostrum to penetrate the mucosa to be absorbed, it may permit the 
entrance of MAP into the animal intestinal wall (Sweeney, 1996). Some animals could 
become asymptomatic carriers and shed the agent during their lives (reviewed in: Chiodini et 
al., 1984). Passive transfer or a pass-through of MAP is referred when a faecal culture 
positive exist together with a tissue culture negative (however the sample collection 
procedure may have neglected the infected sites) (Whitlock, Rosenberger, Sweeney & 
Spencer, 1996). Passive shedding has also been reported after oral inoculation and from 
animal living in a heavily contaminated environment (Hines II et al., 2007; Sweeney, 
Whitlock, Hamir, Rosenberger & Herr, 1992) 
 
2.3 Pathogenesis and Clinical signs 
 
The pathogenesis of Paratuberculosis can be divided into three main stages of infection: 
early infection, subclinical infection and clinical disease (Coussens, 2001).  
MAP is ingested orally with contaminated material. Mycobacteria are transported in vacuoles 
across the M cells to macrophages in Gut Associated Lymphoid Tissue (mainly in Peyer’s 
patches) (Momotani, Whipple, Thiermann & Cheville, 1988). These patches reach their 
maximum development about the time of birth and progressively disappear afterwards 
(reviewed in: Clarke, 1997; Reynolds & Morris, 1983). After undergoing phagocytosis MAP 
organisms suffer degradation activities within the macrophage, are processed and presented 
to T lymphocytes or remain intact inside the phagocytic cell (Coussens, 2001; Stabel, 
2000b). During the subclinical stage of infection there are no clinical symptoms. A granuloma 
develops that may allow the growth of the pathogen inside it by protecting infected cells from 
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cytotoxic immune effects (reviewed in: Coussens, 2001; Zurbrick & Czuprynski, 1987). 
Sporadic destruction of infected macrophages inside granulomas can lead to bacterial 
shedding observed in faecal cultures from subclinically infected animals. Intermittent 
shedding not only provides a way to MAP moving to new infection sites, leading to large 
damage portions of the intestinal tract but also to a continuous low-level stimulation of 
humoral immunity. This could convert a low-undetectable antibody response into detectable 
levels of antibodies in middle to late-stage of subclinical infections (reviewed in: Coussens, 
2001). The initial cell-mediated response of the early and subclinical stages of infection is 
replaced by a non-protective humoral response at the clinical stage (Coussens, 2001; Stabel, 
2000b; Stabel, 2000a) allowing for a rapid dissemination of the infection throughout the host 
(Bendixen, 1978; Stabel, 2000a) and the development of new lesions. 
The balance between host (local and systemic immunity, age), MAP (infective dose, route of 
infection, virulence and survival capabilities) and environmental factors will determine the 
progression from the subclinical stage to the appearance of symptoms. 
The symptoms are usually unspecific like a chronic progressive weight loss with chronic or 
intermittent diarrhoea. However, in advanced stages of infection, animals may show 
mandibular oedema, hypoproteinaemia and become cachetic or even die (reviewed in: 
Clarke, 1997). Correlation between disease progression and some measurable production 
indicators such as milk yield has also been investigated. Although is not an observable 
clinical sign, deviations in milk yield can be used together with other laboratory diagnosis 
techniques to characterize the stage of infection and the animal status, and take 
management measures (Nielsen, Krogh & Enevoldsen, 2009; Nielsen & Toft, 2008). Though 
young animals are the more susceptible to infection, clinical disease generally develops only 
after 3-5 years of age (Chiodini et al., 1984). Animals with clinical signs are considered the 
“tip of the iceberg” (Whitlock & Buergelt, 1996)2. However infected animals have higher 
probability of being culled due to secondary infections, such as mastitis and metritis, than 




Usually the concomitant existence of clinical symptoms, pathological signs and isolation of 
organism are representative of a later stage of the disease in contrast to early stages where 
this association is not a routine finding (Brady, O'Grady, O'Meara, Egan & Bassett, 2008; 
Clarke, 1997; Pavlik et al., 2000; Pérez, Marín & Badiola, 1996). 
In a study of 32 infected cattle by Buergelt et al (1978) the most common pathologic gross 
findings were chronic enteritis, chronic intestinal lymphangitis and mesenteric 
                                                
2 Whitlock & Buergelt (1996) suggested that for each 3 animals with clinical signs (stages III and IV) may exist 8 animals with 
subclinical disease (stage II) and 14 animals with silent infection (stage I) in an population with 25 infected animals. 
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lymphadenopathy with major lesions present at the distal ileum. Other pathological signs 
observed were corrugated and thickened intestinal mucosa, prominent and dilated 
subserosal lymphatics, cachexia, or atrophy of skeletal muscle and fat. Less frequent lesions 
were alopecia, and endocardial and aortic calcification. Gross lesions were detected rarely in 
colon, cecum or rectum (Buergelt et al., 1978). 
Various histopathological lesions types can be observed both in sheep (Carrigan & Seaman, 
1990; Clarke & Little, 1996; Pérez et al., 1996; Rajya & Singh, 1961; Stamp & Watt, 1954) 
and cattle (Buergelt et al., 1978; González et al., 2005). Some theories to explain these 
different lesions types are: (i) that the pathogenicity may vary between MAP strains (Stamp & 
Watt, 1954); (ii) that this variety of lesions is dependent upon the host immune defences 
(Bendixen, 1978; Buergelt et al., 1978; Shulaw, Bechnielsen, Rings, Getzy & Woodruff, 
1993; Stamp & Watt, 1954); (iii) or that different lesions represent different stages of the 
disease (Pérez et al., 1996; Rajya & Singh, 1961). In cattle, the histopathologic lesions were 
described by Buerguelt et al (1978) and by González et al (2005). The latter examined 167 
animals and in 116 (70%) they found MAP infection associated lesions which were 
categorized on focal, multifocal, diffuse multibacillary, diffuse lymphocytic and diffuse 
intermediate. Focal lesions were observed in distal ileum and lymph nodes and were 
described as “well-demarcated, small granulomas formed by macrophages with abundant, 
slightly foamy, pale cytoplasm and large nuclei with sparse chromatin”. On the other hand 
multifocal lesions (the correspondent to the “mild” and “moderate” forms described by 
Buerguelt et al (1978)) correspond to focal and well-demarcated granulomas in intestinal 
lamina propria in addition to lymphoid tissue. It was also observed that sometimes the same 
animal showed lesions in different regions of the intestine. In diffuse lesions (the 
correspondent to the “advanced” lesions described by Buerguelt et al (Buergelt et al., 1978)) 
an inflammatory infiltrate occurred in several areas of the intestine causing diffuse and 
severe granulomatous enteritis. Animals were divided into three different subtypes according 
to the main cell type present in the infiltrate and the amount of acid-fast bacteria (AFB). 
Diffuse multibacillary lesions were named when “macrophages, with foamy cytoplasm and 
also the appearance of epithelioid cells” appeared diffusely infiltrated in the intestinal wall 
and mycobacteria were present in large numbers in all sections of the intestine and lymph 
nodes. Another type of diffuse lesion is the lymphocytic or paucibacillary type where 
“lymphocytes were the main inflammatory cells infiltrating the lamina propria”. Although AFB 
was present, they were always in low numbers. González et al (2005) described also an 
intermediate diffuse category in which the “infiltrate contained abundant lymphocytes, plasma 
cells, giant cells and macrophages, either isolated or forming small granulomas”. However 
there was variation in the cellular content of the infiltrate between animals and between 
samples from the same animal. In this type of lesion mycobacteria were always detected 
(González et al., 2005). 
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Though it is uncertain whether different pathological forms, especially diffuse lesions, 
represent sequential or divergent stages of paratuberculosis, an association between 
histopathologic lesions and immunity responses was transposed from human leprosy to 
ruminant paratuberculosis (mainly in sheep) (González et al., 2005). According to that 
multibacillary lesions may be associated with marked humoral peripheral responses, 
paucibacillary lesions with a strong cellular immune response, and focal lesions with initial or 
latent forms of infection associated with high cellular immune responses (Clarke & Little, 
1996; González et al., 2005; Pérez et al., 1996). 
 
2.5 Danish Paratuberculosis Control Programme 
(adapted from Nielsen (2007) and Nielsen, Jepsen & Aagaard (2007)) 
 
The Danish control programme for paratuberculosis started in February 2006. This voluntary 
programme aims to provide farmers with tools to control paratuberculosis and to reduce the 
prevalence of this disease. The programme follows a risk-based approach at farm level, 
where the cows are classified to different groups representing different stages of infection in 
order to manage the risk according to each risk group. 
By June 2007 approximately 1140 (23%) dairy herds of the 4900 Danish dairy herds joined 
the programme. These herds are primarily large herds with an average herd size of 137 
cow/herd compared to the national average of 110 cows/herd (Nielsen, 2007). The farmer’s 
main purposes of participation in the programme were the certification with 4-10 years, the 
control to avoid production losses, the control to increase animal health and control to 
increase food safety (S.S. Nielsen, personal communication, February 5th, 2009). 
 
2.5.1 Diagnostic testing 
 
The distribution of animals by risk groups is done according to the result of an individual 
antibody ELISA test performed on milk quality control samples without an obligatory 
confirmatory test (faecal culture). An ELISA positive test result is considered when corrected 
optical density values are > 0.3. 
Each herd is tested 4 times a year. Each cow is tested 3 times year (not tested during the dry 
period). This testing scheme and the test used have as objective an early detection of the 
infectious animals being the most sensitive as possible. Due to the high test frequency an 
overall low specificity of the combined test is expected. 
The test gives many positive results due to the focus on sensitivity rather than specificity. 
This characteristics needs to be taken into account in policy making. Every test-positive 
animal is regarded as a possible MAP disseminator, however, there are several types of 
status regarding the test positive results: animals could be infectious; could be infected but 
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still have to progress to disease; could acquire MAP sporadically from a contaminated 
environment; some could be false-positive. 
It is recommended that cows aged 2 – 4 years should be tested more frequently and older 
cows may be tested less frequently (Nielsen & Ersboll, 2006). It was shown that ELISA test is 
able to detect almost all infected cattle that shed MAP (Nielsen & Ersboll, 2006), although the 
age-span of testing positive is from 2 to 11 years of age. With frequent testing most animals 
are detected at the time they are infectious (Nielsen & Toft, 2006). 
 
2.5.2 Risk levels 
 
Regarding the three colour system for risk groups, the test negative animals are referred as 
“Green cows”. These cows, on the day of the test, are considered non-infectious, possibly 
not infected and are considered low risk cows. Cows with the classification Yellow 
(intermittent positive and negative results) and Red (frequent positive results) are infected, 
infectious and considered high-risk cows. The Yellow cows could be in a stage of controlling 
the infection and they may be clinically affected. Red cows are in a stage incapable of 
controlling the infection and are all considered affected. 
Another classification by “infection group” is used to infer differences on milk production 
losses. Based on repeated testing, cows are divided into 6 infection groups regarding their 
antibody profiles (Nielsen, 2007; Nielsen, 2008) (Fig. 1): 
 A0 – repeated negative (minimum 2 samples); 
 A1 – negative, but only 1 test result (usually at the beginning of the 1st lactation); 
 A2 – positive on last sample and negative on previous test; 
 A3 – last 3 tests negative, but with 1 previous positive result; 
 A4 – last result negative, but more positive results have occurred previously 
(fluctuating response); 
 A5 – last 2 or more results positive; 
Cows with positive reactions are considered to be high risk animals and potentially infectious 
but only cows from groups A4 and A5 have reduced milk production3. The allocation of these 
animals in the animal status classification is: 
 Infected – A2, A3, A4, A5; 
 Infectious – A2, A3, A4, A5 – but most important are A4 and A5 (milk yield 
decreased); 
 Affected –A4 and A5. 
                                                
3 A decline in milk production is associated with progression of MAP infection and antibody profiles. It was assessed that milk 
production losses can start 300 days before the first positive antibody test (Nielsen et al., 2009). This information is important to 





Selective culling strategies should be based on the following conditions: repeated high test-
levels; affected animal (with decreased milk yield, diarrhoea, high SCC and other clinical 
signs), within-herd prevalence of Red and Yellow cows; other factors such as lameness, age 
and poor performance in general. Recommendations by the three colour risk groups are: 
 Green older cows are ideal for colostrum production. Green cows may calve other 
Green cows. The hygiene level can be lower than high risk cows; 
 Red cows are recommended not to calve again. Should be culled prior the next 
calving and not allowed near the calving area; 
 Yellow cows may calve again under special conditions. They should calve in an 
isolation of Green cows, should be kept in a single pen and thoroughly cleaned after 
each calving; 
 Yellow and Red cows should not provide milk or colostrum to feed calves. 
 
2.5.4 Herd classification 
 
The probability of freedom of MAP infection among cows in a herd is estimated based on 
annual ELISA testing without obligatory confirmatory testing. This probability is calculated 







A0 Repeatedly Negative Min. 2 times
A1 Negative Only 1 time
A2
Last 3 Negative but 1 previous Positive
(fluctuating response)
Several times
A3 Last Negative but previous Positive Several times
A4 Last Positive but previous Negative Several times















Bacteria establish in gut
Immune response with control
Immune response without control
Destruction of gut tissue
 
 
Fig. 1 – Schematic representation of the different risk levels and risk groups from the Danish ParaTB 
control Programme regarding the pathogenesis of MAP infection (adapted from Nielsen & Toft (2008)).
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2.6 Animal status and Stages of Infection 
 
In the context of this dissertation the stages of infection and the animal status will be 
described. 
 




Inapparent (silent) infection4:  
Is the absence of observable clinical signs and of changes in measurable production 
indicators (Thrusfield, 2005). 
 
Subclinical disease:  
Is defined when “infection occurs without overt clinical signs” but may include changed 




This denomination is used when cattle express typical clinical signs of the disease and 
changes in measurable production indicators. 
 
Affected animals: 
Animals that may have production indicators decreased, such as milk yield or animal weight, 
and/or observable clinical signs of MAP infection; 
 
  
                                                
4 In the context of this dissertation these animals are also considered as “asymptomatic animals”. “Asymptomatic” nomenclature 
is used on the literature revision regarding MAP distribution in tissues, in opposition to “affected” animals because it is broadly 
used in published studies. 
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Stages of Infection description 
 
Three stages of infection were proposed by Coussens (2001) to explain the relation between MAP 
infection, host immunity response and existence of clinical signs. Other authors proposed a four stage 
disease description (adapted from: Whitlock & Buergelt, 1996; Whitlock, Wells, Sweeney & Van Tiem, 
2000) (Fig. 2): 
 
 Stage I – Silent / Inapparent Infection: 
o Age group: Calves, heifers, young livestock up to 2 years; 
o Clinical signs: No; 
o Measurable production indicators (weight and milk yield): Normal; 
o Detectable antibody response: No; 
o Detectable MAP shed in faeces: No; 
o MAP demonstration in tissues: Yes; 
o Possible animal status: Infected. 
 
 Stage II – Subclinical disease: 
o Age group: Adults; 
o Clinical signs: No; 
o Measurable production indicators (weight and milk yield): Decreased; 
o Detectable antibody response: Yes; 
o Detectable MAP shed in faeces: Intermittently; 
o MAP demonstration in tissues: Yes; 
o Possible animal status: Infected, probably infectious and affected. 
 
 Stage III and IV – Clinical disease and Advanced clinical disease: 
o Age group: Adults; 
o Clinical signs: Yes; 
o Measurable production indicators (weight and milk yield): Decreased; 
o Detectable antibody response: Yes; 
o Detectable MAP shed in faeces: Yes; 
o MAP demonstration in tissues: Yes; 









































Fig. 2 – Schematic representation of “The Iceberg Effect” and the Stages of Infection in an infected 
herd. Proportions adapted from Whitlock & Buergelt (1996) considering a population of 100 animals 
with 25 infected.  
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2.6.2 Animal Status 
 
The following animal status classification was proposed on an evaluation study of the 
diagnostic tests accuracy and will be adopted in this dissertation. Animals were classified in 
Infected, Infectious and Affected (adapted from: Nielsen & Toft, 2008) (Fig. 3): 
  
 
 Infected animals: 
o In these animals MAP persistence lasted long enough to stimulate an immune 
response, to produce clinical signs or to be detected by agent cultivation; 
o Cattle assigned to this status may become infectious and affected in later 
stages of infection; 
o It is assumed that once a cow has an established infection, the infection 
persists for life; 
o These animals pose a risk of becoming infectious and cannot be declared 
MAP-free; 
o They are an economic burden when there is decrease in milk/weight and 
transmission to other animals. 
 
 
 Infectious animals: 
o These animals shed MAP at the time of testing according to the test used; 
o Their infectious status can also be decided on the basis of the detection of an 
immune response (Nielsen, Grohn & Enevoldsen, 2002); 
o These animals are considered infected and may be affected; 
o They may include non-infected animals which may be passive shedders of 
MAP (transient infectious status); 
o MAP shedding is mainly observed in faeces, but it may also occur in milk and 
be transferred in utero. 
o These animals are considered an economic burden because in short-term 
they experience decreased milk production and on long-term they transmit 










 Affected animals: 
o This status is assigned when cattle have decreased milk yield or weight loss 
(or any other production indicator) and/or clinical signs characteristic of MAP 
infection; 
o These animals are considered infected and probably infectious;  
o Their value is low because they may have reduced milk yield, decreased 







Fig. 3 – Schematic representation of the different animal status in an infected herd population. 




2.7 MAP diagnostic methods 
 
None of the available diagnostic methods are 100% MAP specific and sensitive. Thus, 
detection and characterization of MAP infections are a hard task. MAP infection may be 
detected by clinical diagnosis or laboratory techniques. Due to the dynamics of MAP infection 
both options are dependent on the stage of infection and animal status.  
 
MAP clinical signs were described previously. Usually they are associated with advanced 
stages of infection and must be confirmed by laboratory techniques. MAP suspicion by 
clinical diagnosis is influenced by veterinarian diagnostic skills, herd owner disease 
knowledge and capacity to detect affected animals, and the type of clinical signs. Clinical 
diagnosis sensitivity and specificity are unknown. In some countries, due to specific MAP 
legislation, the fear of being officially classified as MAP infected herd results in 
underreporting of suspicious signs. This fact decreases the sensitivity of the clinical 
diagnosis (Anon, 2004b). 
 
A laboratory diagnostic test should be chosen based on the analyte to be detected (bacteria, 
bacterial constituents, immune response). Due to dynamics of the MAP infection the immune 
response, bacterial load, potential shedding or MAP dissemination through the host do not 
necessarily follow the same pattern or time course. Therefore, the major obstacle for 
obtaining a correct diagnosis is the time-dependent responses (Nielsen, 2002). 
Two main diagnostic patterns can be followed: techniques that detect the agent and techniques that 
detect the immune response. MAP laboratory diagnosis methods were described elsewhere (Nielsen, 




































Fig. 4 – Summary of most commonly used MAP diagnostic tests. IFN-γ – Interferon Gamma; CF – 
Complement Fixation; AGID - Agarose Gel Immunodiffusion; ELISA - Enzyme-Linked Immunosorbent 
Assay (adapted from Nielsen et al.(2001). 
 
2.7.2 Agent detection tests 
 
Agent detection is one of the most used methods to diagnose MAP infection. Several 
matrices have been used to detect MAP such as faeces, milk and other tissues. Depending 
on the method used, the detected analyte may be the bacteria (bacterial stain – ZN, culture) 
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or bacteria and/or its constituents (PCR techniques). As a basic principle for agent detection, 
MAP must be present in the sample and available in detectable quantities. MAP isolation 
major problem is to ensure that MAP is present in the collected sample. About tissue culture, 
Whitlock et al (1996) mentioned that it may be necessary to collect samples from up to 100 
sites per animal in order to obtain a positive culture of tissue specimen from an infected 
animal. Thus the sampling collection method, the sample processing steps and the agent 
detection method chosen are very important aspects to bear in mind. 
 
2.7.2.1 Decontamination and concentration methods 
 
In order to reduce fungal and bacteriologic contamination an appropriate decontamination 
procedure is necessary. MAP cells may be damaged and growth inhibited. The HPC 
(hexadecylpyridinium chloride) has been the most commonly used decontaminant, but others 
have also been reported e.g. benzalkonium chloride and oxalaic acid (reviewed in: Nielsen et 
al., 2001).  
Pre-incubation methods and the use of antimicrobial agents have also been described. Some 
associations between chemical and antimicrobial agents for decontamination and culture 
methods are recommended (reviewed in: Nielsen et al., 2001). 
To increase MAP recovery from samples concentration methods should be applied before 
cultivation process. Centrifugation and sedimentation methods are used but the former is 
described as having higher detection and lower contamination rates. Filtration is a technique 
used to concentrate MAP samples using the MAP cell clumping property. Immunomagnetic 
separation (IMS) is also used to extract MAP from heterogeneous samples. It has been used 
in milk samples and also prior to PCR (reviewed in: Nielsen et al., 2001). 
 
2.7.2.2 Culture-based methods 
 
Since its first isolation by bacteriologic culture, MAP isolation methods have evolved a lot but 
special growth requirements and some difficulties on the cultivation continue to be the main 
obstacles. In order to reduce the presence of fungi and other bacteria the decontamination 
step is particularly important. Isolates should be submitted to mycobactin dependency tests 
to differentiate it from other mycobacteria,5 (reviewed in: Manning & Collins, 2001).  
Two types of culture methods are available: conventional and radiometric. MAP growth 
velocity is different between methods. The conventional method takes between 12 and 16 
weeks, while radiometric method takes only 5 to 8 weeks. The time difference is due to the 
                                                
5 MAP growth only on media supplemented with mycobactin J, an iron chelator required for in-vitro Map growth. The sample is 
streaked to media with mycobactin and to media without mycobactins, and the growth patterns are compared (reviewed in: 
Manning & Collins, 2001). 
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detection process. In the conventional method, slants of media are inspected until a colony is 
visible. In the radiometric method, a machine monitors sample-inoculated bottles of media for 
14C-labelled products of bacterial metabolism. Metabolic products are detectable before the 
organism forms a colony sizeable enough to be observed on standard slants of media by 
naked eye. Both the analytical and the diagnostic sensitivity of the radiometric method are 
higher than the conventional culture. The automation of the process is another advantage 
(reviewed in: Manning & Collins, 2001). 
Herrold’s Egg Yolk and Löwenstein-Jensen mediums complemented with mycobactins J are 
the most used mediums in conventional culture. Regarding the radiometric type, a 
commercial product known as the BACTEC system is used (reviewed in: Nielsen et al., 
2001). 
Culture methods sensitivity and specificity are dependent on several aspects. MAP tissue 
culture sensitivity and specificity have not been estimate thoroughly but they were reported 
elsewhere: sensitivity - 4% [0.2% - 15%] ; specificity – 97% [92% - 99%] (reviewed in: Anon, 
2004b). Regarding faecal culture, the results were reported by animal status: Affected, Se – 
70%, Sp – 100%; Infectious, Se – 74%, Sp – 100%; Infected, Se – 23% - 29%, Sp – 98% 
(Nielsen & Toft, 2008).  
 
2.7.2.3 Non culture-based methods 
 
IS900 has been used as the MAP genetic marker on PCR techniques since the discovery of 
the insertion sequence. IS900-based PCR can be applied directly on samples or as a 
confirmatory step after conventional culture, radiometric culture or immunomagnetic 
separation processes (reviewed in: Nielsen et al., 2001).  
Due to its high sensitivity and fast response it is broadly used. However it also has some 
limitations. False-negative reactions may occur due to the presence of certain substances 
such as urea, haemoglobin or heparin that may inhibit enzymatic reactions; and MAP cell 
wall resistance. False-positive reactions are also described and may be caused by: 
laboratory contamination; IS900 sequence is not so MAP specific, as it was previously 
assumed – “IS900-like sequences” (Englund, Bolske & Johansson, 2002; Cousins et al., 
1999); and amplification of DNA from dead bacteria and spheroblasts – these PCR positive 
results may be considered as a false-positive reaction when used together with a culture 
method (they will give a culture negative result) (reviewed in: Nielsen et al., 2001). 
Although its drawbacks, IS900-based PCR is a fast technique and it is currently the method 
used to detect MAP infection in samples where MAP spheroblasts (viable and non-cultivable 




The Se and Sp of direct PCR on faecal samples were reported: Se – from 2% [0% - 5%] to 
39% [10% - 90%]; Sp – 98% [95% - 100%] (Anon, 2004b). 
 
Another method of agent detection is by direct stain of samples followed by microscopic 
examination. Direct acid-fast staining of faecal samples has a low sensitivity and is very 
difficult to accurately distinguish MAP from non-pathogenic bacteria. Tissues direct staining 
is a commonly used process on samples collected at necropsy or by biopsy. Usually the 
Ziehl-Neelsen (ZN) acid-fast stain is the method used to highlight rod-shaped organisms 
(reviewed in: Manning & Collins, 2001). 
MAP identification by PCR techniques and by ZN may be hampered in paucibacillary forms 
of disease (reviewed in: Manning & Collins, 2001). 
 
2.7.3 Immune response detection tests 
 
To measure an immune response, first it must have occurred at a detectable intensity 
regarding the test used and the timing of the testing. Measurable immunological reactions 
can be grouped into cell-mediated or humoral immune responses. In the former, the skin test 
(intradermal injection of a MAP purified protein derivate) and interferon-gamma (IFN-γ) can 
be used. In humoral immune responses, the agarose gel immunodiffusion (AGID) test, the 
complement-fixation (CF) test and the absorbed indirect enzyme-linked immunosorbent 
assay (ELISA) are the most commonly applied tests (reviewed in: Nielsen et al., 2001). 
None of the mentioned tests is perfect (Se – 100%; Sp – 100%) and one of the major 
difficulties in their evaluation is the use of bacteria detection as the “gold standard” of 
infection. As bacteria detection methods are not perfect, the test results may be over or 
underestimated. 
False-positive reactions in serological tests may be due to cross-reactions with other micro-
organisms because the antigens used are crude and may contain antigens common to other 
bacteria of the order Actinomycetales. On the other hand, the animal may develop a 
protective immunologic response, recover after being exposed and be considered resistant. 
The problem of differentiating between resistant and infected animals is difficult to overcome 
by immunologic techniques since these methods give an indication of exposure, not infection 
(reviewed in: Chiodini et al., 1984).  
False-negative responses may occur due to an insufficient antibody level (e.g. early 
infection) or to a state of anergy developed in clinical cases attributable to the protein-losing 
enteropathy. An animal that had responded to antigen but fail to respond in subsequent 
testing may be anergic to that specific antigen and infected or may have recovered from 





2.7.3.1 Humoral immune response detection methods 
 
AGID test is considered less sensitive than ELISA and the CF. Its high specificity may be a 
result of the low analytical sensitivity (high-antibody detection limit). The CF test is reported 
to detect antibodies later than ELISA and its specificity is considered lower than AGID and 
ELISA (reviewed in: Nielsen et al., 2001). 
 
ELISA is the most commonly used test to detect humoral immune response in MAP infection. 
Due to the pre-absorption with Mycobacterium phlei6 the sensitivity is improved. Results 
depend on the chosen cut-off point and the diagnostic test used as standard. The key factor 
in the determination of the ELISA efficacy is the type of antigen used (reviewed in: Buergelt 
et al., 2004). 
ELISA sensitivity and specificity are dependent on several factors such as stage of infection 
and animal status. Estimates of ELISA specificity and sensitivity for serum and milk samples 
were described regarding the animal status (Nielsen & Toft, 2008). 
 
Table 1 – Range of reported sensitivity (Se) and specificity (Sp) of serum antibody ELISA (SELISA) 
and milk antibody ELISA (MELISA) for three animal statuses: affected, infectious and infected. 
 
  SELISA MELISA 
Animal Status Se Sp Se Sp 
Affected 50% - 87% No data No data No data 
Infectious 24% - 94% 40% - 100% 21% - 61% 83% - 99% 
Infected 7% - 22% 85% - 100% 39% 96% - 100% 
 
(adapted from: Nielsen & Toft, 2008) 
 
2.7.3.2 Cell-mediated response detection methods 
 
Intradermal testing and detection of interferon-gamma are used to detect cell-mediated 
immune response in MAP infection. The former is based on the delayed-type hypersensitivity 
(DTH) after intradermal injection of the antigens. A MAP purified protein derivate (PPD) is 
inoculated and the reaction (skin thickness) is measured. This test was replaced due to the 
lack of specificity and the poor correlation with the infectious status of the animal (reviewed 
in: Nielsen et al., 2001). 
 
                                                
6 Saprophytic bacteria existent in intestinal surface (reviewed in: Chiodini et al., 1984). 
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Interferon-gamma (IFN-γ) cytokine, released by sensitized lymphocytes after exposure to 
appropriate antigens, is another way used to detect cell-mediated immune responses 
(reviewed in: Nielsen et al., 2001).  
It is gaining increasing acceptance due to the possibility of detection of infected animals in an 
earlier stage of infection (during cell-mediated immune response stage).  
Its major drawback is the time span from blood sample collection to the start of culture 
because it will influence the cells viability (Mikkelsen, Jungersen & Nielsen, 2009). On the 
other hand non-specific reactions, different responses of species to the non-specific 
stimulant, interpretation issues and the time consuming nature of the protocol are other weak 
points of this test (reviewed in: Manning & Collins, 2001). 
Its characteristics were described only for the infectious animal status: Se – from 13% to 













Among findings related to infection with MAP, lesions at the gastro-intestinal tract are the 
most commonly described. However, some authors have not only found gross and 
histopathologic lesions, but also isolated and identified MAP by culture and PCR in tissues 
outside the intestinal tract. Considering this aspect of MAP infection as a disseminated 
infection7 a literature revision was made to: (i) identify previous studies on which isolation of 
MAP in tissue cultures was described; (ii) detect which tissues are more frequently analyzed 
and which tissues require further attention; (iii) assess the prevalence of MAP contamination 
in each tissue; (iv) make recommendations for a future study to assess MAP distribution in 
tissues in order to quantify inputs necessary to a risk assessment. 
 
 
3.2 Materials and Methods 
 
An electronically literature search was made using the Medline/Pubmed database. The 
search terms were paratuberculosis, Johne’s or Johnes, culture, isolation, tissues, milk and 
beef. Due to the amount of results and the difficulty of reach the important articles through 
the article title or abstract, a manually literature search was made. This manual search used 
the study from Antognoli et al (2008) as a starting point to reach other important articles 
about MAP isolation by tissue culture. As inclusion criteria, MAP isolation must be done by 
tissue culture and the information of positives/total sampled need to be described for each 
tissue. Only studies regarding cattle were considered. It was decided not to stipulate more 
specific criteria. However, some important characteristics from each study are pointed so 
their objectives, study design and methodology can be understood. The main reasons for this 
decision were the fact that there are few published data and because the date of publication 
differed substantially (1929-2009) between studies, with differences on the method used to 
detect MAP distribution on tissues. For each study the following information was selected: 
clinical status, purpose of the study, husbandry type, age range, clinical status description, 
sample size, sampling method, cross-contamination precautions, type of infection and type of 
study and tissue collection. 
 
The number of MAP positive tissues and samples collected were also recorded. For each 
sampling site the apparent prevalence (positives/sampled) was calculated and for each 
                                                
7 (Dennis et al., 2008; Antognoli et al., 2008; Alonso-Hearn et al., 2009; Hines et al., 1987; Pavlik et al., 2000); 
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prevalence estimate the 95% Wilson Score Interval (Confidence Interval) was calculated 
(Brown et al., 2001). 
 
/
/ / ⁄ /
/ ⁄
 




A total of 48 studies met the criteria for inclusion. Study information and study results were 
recorded and three main tables were constructed: In Table 2 and Table 3 the study details 
are shown and grouped by clinical status, purpose of the study, husbandry type and age 
range; in Annex 1 the tissue culture results are grouped by tissue; in Table 4 and Table 5 the 
prevalence and 95% Confidence intervals are grouped by tissue summary – results from 





The studies were firstly grouped by “clinical status” since it is relevant to know if the culture 
positives tissues came from an “affected animal” (with decreased production indicators 
and/or clinical signs), which could be rejected at the slaughterhouse based on observable 
signs, or if they came from an “asymptomatic/not affected” infected animal (without clinical 
signs and decreased production indicators). This last group of animals with possible 
contaminated tissues will easily enter into the food chain if no precautions are taken to detect 
MAP in tissues consumed by humans. In 48 studies, 1 study (Doyle, 1958) did not fit to any 
of these categories because the detection of MAP was only made in foetus tissues from 
cows clinically affected with Johne’s disease; 25 studies were about “asymptomatic” animals; 
9 studied asymptomatic and affected animals; 13 studies defined their studied object as 
“affected” animals. This last group included animals that shown clinical signs and/or changes 
in production indicators such as reduction of milk yield.  
 
Some authors did not clearly specify the clinical status of the animals. Cattle were 
considered asymptomatic for three reasons: (1) too young assuming the usual age for 
manifestation of clinical signs8; (2) because the time between experimental exposure to the 
agent and slaughter was too short for the manifestation of clinical signs; (3) because the 
animals were “abattoir animals” approved at the ante mortem inspection. 
                                                




The reasons for categorizing the animals as asymptomatic on the studies mentioned above 
were: in Macdonald et al (1999) animals were culled between 21 and 29 months old; in 
Beard et al (2001) “no animal exhibited signs of diarrhoea or weight loss during the 6-month 
incubation period”; in Paine and Rankin (1961b) the oldest animal culled was 17 months old; 
in Larsen et al (1975) the animals were culled 150 days after exposure; in Paine and Rankin 
(1961a) the oldest calf was 9 months old and all cattle were culled 6 months after exposure. 
Animals were considered asymptomatic because they were abattoir animals in McNab et al 
(1991), McKenna et al (2004), Jorgensen (1965), Pavlik et al (2000), and in Whitlock et al 
(1997); in Ayele et al (2004) the reason to assume that animals were asymptomatic was 
because some were calves between 6 and 28 weeks old and others were asymptomatic 
breeding bulls that were culled based on a faecal culture positive test. 
Most of the studies described affected animals as cattle with “clinical signs of disease” 
without specifying those signs. (Category CSD – “Clinical signs of Disease” - in field “Clinical 
Status description”). 
 
Animals were considered in the “Both” category on the study from Huda and Jensen (2003) 
because they described them as “subclinically and clinically infected animals”. Some 
exhibited clinical signs compatible with paratuberculosis while others had signs of mastitis, 
lameness or reproductive disorders. The same applies to the study of Kopecky et al (1967) 
were some animals were culled with CSD while others were culled due to other reasons. The 
study by Rossiter and Henning (2001) was included in the category “Affected” because 
animals had a low body condition score, and were considered “at high risk of clinical 
infection”.  
 
The characteristics of the reviewed studies where MAP was isolated by tissue culture are in 
Table 2 and Table 3 9. 
 
                                                
9 C.S. – Clinical Status; Purp. – Purpose; Husb. – Husbandry; Cross-cont. – Cross-contamination; Inf. – Infection; col. – 
collection; Na – Not applicable; Nd – No data; Path – Pathogenesis studies; Prev – Prevalence studies; Tdist – Tissue 
distribution studies; Dtests – Diagnostic test evaluation studies; CSD – Clinical signs of disease; FC – Fecal culture; NR – Non-
random; R – Random; E – Experimental; N – Natural; CrSe – Cross-sectional; CaSt – Case Study; CrSe F – Cross-sectional 
with follow-up; Rep CrSe – Repeated Cross-sectional; TC – Tissue culture; PCR – Polymerase chain reaction; < 2 years – 
younger than 2 years old; ≥ 2 years – with or older than 2 years old; D – Diarrhoea; W – Weight loss; Abt – Abattoir animals; M 
– Milk yield decreased; Rt – Routine; It – Intensive. 
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Path Dairy < 2 y D, W 21 Na Nd E E Rt (Thorel, Pardon, Irgens, Marly & Lechopier, 1984) 
Prev Both ≥ 2 y Abt, W 539 NR Nd N CrSe It (Rossiter & Henning, 2001) 
 Dairy ≥ 2 y D, W 11 NR Yes N CrSe It (Giese & Ahrens, 2000) 
Tdist Both ≥ 2 y CSD 6 NR Yes N CaSt It (Larsen & Kopecky, 1970) 
Dairy ≥ 2 y D, W, FC+ 1 Na Yes N CaSt It (Larsen et al., 1981) 
D, W, ELISA+ 40 NR Yes N CrSe It (Antognoli et al., 2008) 
CSD 34 NR Yes N CrSe It (Doyle, 1954) 
D, W, M 1 Na Nd N CaSt It (Hines et al., 1987) 
D, W 7 NR Yes N CaSt It (Koenig et al., 1993) 
CSD 26 NR Yes N CrSe F It (Taylor et al., 1981) 
D, W 4 NR Nd N CaSt It (Alexejeff-Goloff, 1929) 
CSD 24 NR Yes N CaSt It (Lawrence, 1956) 









Dtests Dairy ≥ 2 y As 29 Na Nd Both E Rt (McDonald, Ridge, Hope & Condron, 1999) 
  Nd As 1493 NR Yes N CrSe It (Jayarao et al., 2004) 
  As 24 R Yes N CrSe It (Paolicchi et al., 2003) 
Path Beef < 2 y As 12 Na Nd E E It (Stabel, Palmer & Whitlock, 2003) 
Dairy < 2 y As 18 Na Nd E E Rt (Beard et al., 2001) 
As 4 Na Nd E E Rt (Saxegaard, 1990) 
As 21 Na Nd E E It (Payne & Rankin, 1961b) 
As 26 Na Yes E E It (Gilmour, Nisbet & Brotherston, 1965) 
≥ 2 y As 5 Na Nd E E It (Rankin, 1961a) 
All As 8 Na Nd E E Rt (Larsen et al., 1975) 
As 16 Na Nd E E It (Payne & Rankin, 1961a) 
Prev Both ≥ 2 y Abt 400 R Nd N CrSe Rt (Smith, 1954) 
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Prev Both ≥ 2 y Abt 400 NR Nd N CrSe Rt (McNab, Meek, Duncan, Martin & Vandreumel, 1991)
   As 7540 R Nd N Rep CrSe Rt (Merkal, Whipple, Sacks & Snyder, 1987)
Dairy ≥ 2 y Abt 100 R Nd N CrSe It (Chiodini & Vankruiningen, 1986)
Abt 984 R Nd N CrSe Rt (McKenna et al., 2004)
All Abt 1110 NR Nd N CrSe Rt (Jorgensen, 1965)
Nd As 86 NR Yes N CrSe It (Ayele et al., 2005)
As 211 NR Nd N CrSe It (Pillai & Jayarao, 2002)
Tdist Both ≥ 2 y Abt 611 NR Nd N CrSe It (Pavlik et al., 2000)
Dairy ≥ 2 y As, Abt, FC+ 171 NR Yes N CrSe It (Whitlock et al., 1996)
 Abt, FC+ 86 NR Yes N CrSe It (Sweeney et al., 1992b)
 As 58 NR Yes N CaSt It (Sweeney et al., 1992a)
All As 14 NR Yes N CrSe It (Ayele, Bartos, Svastova & Pavlik, 2004)




Dtests Dairy ≥ 2 y D, W, M, other 15 NR Yes N CrSe It (Huda & Jensen, 2003)
Path Dairy ≥ 2 y As, CSD 23 Na Nd Both E It (Taylor, 1953)
 As, M, CSD 9 Na Nd E E It (Rankin, 1961b)
All As, D, M 6 Na Nd E E It (Rankin, 1958)
Prev Dairy ≥ 2 y, Nd CSD 33 NR Yes N CrSe It (Smith, 1960)
Tdist Dairy ≥ 2 y Abt, CSD 407 NR Yes N CrSe It (Seitz et al., 1989)
CSD, other 148 NR Nd N CrSe Rt (Kopecky, Larsen & Merkal, 1967)
Both ≥ 2 y M, ELISA+, D, 
W, Faecal PCR+
47 NR Yes N CrSe It (Alonso-Hearn et al., 2009)
Nd Nd Abt, D, W 21 NR Yes N CrSe It (Brady et al., 2008)
Na Tdist Na Na Na 24 NR Nd N CrSe It (Doyle, 1958)
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Purpose of the study 
 
The studies analyzed were categorized by their main objective and divided into 4 groups: 
Diagnostic test evaluations, Pathogenesis, Prevalence and Tissue distribution studies.  
The studies included in the first group performed tissue culture as the confirmatory method to 
other diagnostic tests.  
The Pathogenesis studies were all experimental studies with experimental infection. Their 
main objective was to evaluate the characteristics of the agent and different aspects of the 
disease pathogenesis.  
When their main goal was to estimate the prevalence in a specific geographical region by 
detecting MAP in tissues, e.g. prevalence studies at slaughterhouse, they were included in 
the Prevalence group.  
If the isolation of MAP from a specific location or the demonstration of a generalized infection 
were the aim of the study, they were considered as an evaluation of MAP distribution in 
tissues.  
This division was made because different study purposes and different methods used to 




Studies were also grouped in dairy or beef cattle since different market purposes determine 
different management schemes and consequently different environmental factors that may 
predispose to infection. In the studies of Larsen and Kopecky (1970), Smith (1954) and 
McNab et al (1991) the husbandry type was assumed to be dairy and beef because these 
studies were made at a slaughterhouse. So there are some odds that both types of cattle 
were slaughtered. 
Merkal et al (1987), Pavlik et al (2000), Rossiter and Henning (2001) differentiate their results 
by type of husbandry. Alexejeff-Goloff (1929) and Lawrence (1956) did not specify the type of 
study animals. However at least one was dairy so all were considered as dairy cattle. Most 




As age affects disease progression it may also influence the dissemination of MAP in 
tissues. The age at slaughter was used to difference two age ranks: < 2 years old and ≥ 2 
years old. When no clear information about the age of the studied animals was given, 
animals were considered older than 2 years old if the study was done at an abattoir. In the 
studies from Alexejeff-Goloff (1929), Alonso-Hearn et al (2009), Doyle (1954), Giese and 
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Ahrens (2000), and Taylor et al (1981) cattle were also considered older than 2 years old 
since the authors reported all were clinically affected animals. In 29 of 48 (60%) of studies 
animals were ≥ 2 years old. 
 
Clinical status description 
 
If this information was available an attempt was made to describe the clinical status of the 
animals. When clinical signs different than the classical signs of paratuberculosis were stated 
they were classified as “other”. In Huda and Jensen (2003) “other” signs were mainly 
reproductive disorders, mastitis and lameness. In Kopecky et al (1967) they were mastitis, 
respiratory disorder and lumpy jaw. When there was mention of clinical signs without a 




In Table 2 and Table 3 sample size represents the maximum number of animals with tissues 
analyzed. In Annex 1 the number of samples collected by each tissue is given10. In some 
studies, tissue collection was not carried out in all sampled animals either by author’s option 




The sampling method was categorized in random or non-random. The sampling method 
used by Merkal et al (1987) and Smith (1954) was considered random because both were 
abattoir studies where the authors avoid the selection of animals from the same herd by 
systematic sampling (the first collect samples with 1 hour interval and the second on different 
days). Most of the studies were considered “non-random” because the selection was based 
on previous animal/herd positive diagnostic tests, observation of clinical signs of disease or 




They were considered when the author demonstrated awareness of the possibility of cross-
contamination for example, faecal contamination in milk during milk collection; bacterial 
contamination between tissues and materials; faecal contamination in tissues collection at 
                                                
10 For each animal several tissues could be gathered. For each tissue only one sample per tissue was considered. In cases 
where several samples were gathered from the same tissue and gave different results - some positive and others negative, it 
was recorded only as one positive sample (or if all negative – one negative sample). 
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the abattoir; and aseptic procedures in sample collection11. It was present in 23 of 48 (48%) 
studies. 
 
Type of tissue collection 
 
Tissue collection was described as intensive or routine. If only gastro-intestinal samples were 
collected, studies were marked as “Routine”, if gastro-intestinal and/or other tissues were 
collected, the studies were designated as “Intensive”. 
 
3.3.1 Animal population characterization 
 
From all 15004 studied animals, 22485 samples were analyzed giving an average of 1.5 
samples per animal. 2297 samples were MAP culture positive (10.3%). 
Approximately 90% of the studied animals were asymptomatic animals (77% of the collected 
samples), while only 5% were affected animals (13% of the collected samples) (“Both” and 
“NA” categories together accounted for 5% of animals and 10% of samples).  
The majority of the animals – 76% (64% of samples) was tested in “prevalence studies”, 13% 
of the total animals (18% of samples) were tested in “tissue distribution studies”, 1% (9% of 
samples) in “pathogenesis studies”, and 10% (9% of samples) in “diagnostic test studies”. 
Concerning the husbandry type, approximately 60% were dairy cattle (67% of samples) and 
26% beef cattle (23% of samples) (“Both”, “ND” and “NA” represented together 14% of 
animals and 10% of samples).  
In relation to age approximately 83% were ≥ 2 years old (81% of samples) and only 4% were 
< 2 years old (8% of samples) (“NA” and “ND” summed 13% of animals and 11% of 
samples). 
Regarding the type of infection, 98% of animals (90% of samples) had natural infection while 
only 1% (8% of samples) was submitted to experimental infection. Only 1% of animals (2% of 
samples) belong to studies where both types of infection were present. Regarding the study 
type, if we regroup the several cross-sectional studies in a single “general” cross-sectional 
study category they ensemble 98% of the analyzed animals (89% samples), while 
experimental studies represented 1% (10% samples) and case studies also 1% (1% 
samples).  
Although the number of studies with random sampling was low, they covered 60% of the 
tested animals (47% of samples). Non-random sampling was used for 39% of animals and 
43% of samples; “NA” was 1% of animals and 10% of samples. 
                                                
11 e.g. Non-gastrointestinal tissues collected first; udder cleaning and disinfection procedures in milk collection; sterile materials. 
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Due to the lack of information about cross-contamination precautions and aseptic 
procedures, the studies that provided this information covered only 18% of the tested 
animals (23% of samples).  
Though most studies were categorized as based upon an intensive method of tissue 
collection, they represented 29% (46% samples) while routine methods represented 71% of 
the tested animals (54% samples). 
 
3.3.2 Characterization of analyzed tissues 
 
A total of 56 different tissues were cultured for MAP and were categorized into 10 different 
tissue sections: 9 sections of gastro-intestinal mucosa (16%), 8 sections of gastro-intestinal 
lymphoid tissue (14%), 16 types of other lymphoid tissue (29%), 4 internal organs (7%), 
genitourinary tract (14%), and 11 other tissues (20%). The number of positive and samples 
were summarized per tissue and the prevalence were calculated (Annex 1). Whenever 
























Table 4 – Results from Annex 1 summarized by tissue12 (Part 1). Prevalence (Prev.) and 95% 
Confidence interval (CI) of MAP culture isolation by tissue and larger tissue sections. 
 
Intestinal Mucosa Summaries Positives Samples collected Prev. 95% CI 
Colon muc. 32 96 33.3% 24.7% 43.2%
Cecum muc. 40 121 33.1% 25.3% 41.8%
Ileo-cecal valve muc. 119 397 30.0% 25.7% 34.7%
Jejunum muc. 54 183 29.5% 23.4% 36.5%
Rectum muc. 18 100 18.0% 11.7% 26.7%
Duodenum muc. 20 115 17.4% 11.5% 25.3%
Pylorus muc. 6 37 16.2% 7.7% 31.1%
Ileum muc. 160 1272 12.6% 10.9% 14.5%
Abomasum muc. 4 44 9.1% 3.6% 21.2%
Others 131 188 69.7% 62.8% 75.8%
Intestinal Mucosa 584 2553 22.9% 21.3% 24.5%
GI Lymphoid Tissue  Summaries Positives Samples collected Prev. 95% CI 
Colic LN 8 12 66.7% 39.1% 86.2%
Jejunal LN 13 30 43.3% 27.4% 60.8%
Ileal LN 14 42 33.3% 21.0% 48.4%
Mesenteric LN 181 617 29.3% 25.9% 33.0%
Jejunal Peyer's Patches 5 18 27.8% 12.5% 50.9%
Duodenal LN 4 29 13.8% 5.5% 30.6%
Cecal LN 8 100 8.0% 4.1% 15.0%
Ileocecal LN 436 10757 4.1% 3.7% 4.4%
Others 23 47 48.9% 35.3% 62.8%
GI Lymphoid tissue 692 11652 5.9% 5.5% 6.4%
Others 253 1035 24.4% 21.9% 27.2%
GI tract 1529 15240 10.0% 9.6% 10.5%
Head Lymphoid Tissue Summaries Positives Samples collected Prev. 95% CI 
Suprapharyngeal LN 19 37 51.4% 35.9% 66.6%
Submaxilar LN 18 41 43.9% 29.9% 59.0%
Retropharyngeal LN 34 122 27.9% 20.7% 36.4%
Mandibular LN 6 51 11.8% 5.5% 23.4%
Tonsil 14 178 7.9% 4.7% 12.8%
Parotid LN 0 37 0.0% 0.0% 9.4%
Others 27 40 67.5% 52.0% 79.9%
Head Lymphoid tissue 118 506 23.3% 19.8% 27.2%
  
                                                
12 Only one sample per tissue per animal was used. In each tissue summary, the number of “Positives” and “Samples collected” 
per tissue also represent the number of sampled and positive result animals. (e.g. In colon mucosa 96 samples from 96 animals 
were collected and 32 gave positive result which means 32 positive animals). One exception is muscle tissue, where 167 
samples do not correspond to 167 but to 87 animals, because the 3 different muscles from Antognoli et al (2008) were here 
grouped (corresponding to 40 animals and not to 120 animals). On the other hand, e.g. 2553 samples collected from tissues 
from intestinal mucosa (summary) do not represent 2553 analyzed animals because in the same study, the same animal may 
have had various tissues from intestinal mucosa analyzed. 
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Table 5 – Results from Annex 1 summarized by tissue (Part 2). Prevalence (Prev.) and 95% 
Confidence interval (CI) of MAP culture isolation by tissue and larger tissue sections. 
 
Other LN Summaries Positives Samples collected Prev. 95% CI 
Hepatic LN 94 221 42.5% 36.2% 49.1%
Pulmonary LN 32 82 39.0% 29.2% 49.8%
Mediastinal LN 28 134 20.9% 14.9% 28.5%
Supramammary LN 52 251 20.7% 16.2% 26.2%
Precrural LN 6 37 16.2% 7.7% 31.1%
Iliac LN 11 69 15.9% 9.1% 26.3%
Prescapular LN 18 127 14.2% 9.2% 21.3%
Popliteal LN 19 660 2.9% 1.9% 4.5%
Superficial Cervical LN 7 539 1.3% 0.6% 2.7%
Bronchial LN 0 37 0.0% 0.0% 9.4%
Others 13 19 68.4% 46.0% 84.6%
Other LN 398 2682 14.8% 13.5% 16.2%
All Lymphoid tissue 1090 14334 7.6% 7.2% 8.0%
Internal Organs Summaries Positives Samples collected Prev. 95% CI 
Lung 20 119 16.8% 11.2% 24.5%
Spleen 32 201 15.9% 11.5% 21.6%
Kidney 13 98 13.3% 7.9% 21.4%
Liver 54 798 6.8% 5.2% 8.7%
Genitourinary tract Summaries Positives Samples collected Prev. 95% CI 
Prostate 4 7 57.1% 25.0% 84.2%
Seminal vesicles 9 20 45.0% 25.8% 65.8%
Ovaries 5 18 27.8% 12.5% 50.9%
Uterus 24 163 14.7% 10.1% 21.0%
Epididymis 2 14 14.3% 4.0% 39.9%
Testes 3 22 13.6% 4.7% 33.3%
Bulbourethral gl. 2 17 11.8% 3.3% 34.3%
Bladder 1 12 8.3% 1.5% 35.4%
Other Tissues Summaries Positives Samples collected Prev. 95% CI 
Semen 3 3 100.0% 43.8% 100.0%
Uterine flush fluid 3 4 75.0% 30.1% 95.4%
Others 30 55 54.5% 41.5% 67.0%
Collection chamber flush fluid 2 6 33.3% 9.7% 70.0%
Mammary Gland 11 56 19.6% 11.3% 31.8%
Plasma 1 7 14.3% 2.6% 51.3%
Pharynx 4 37 10.8% 4.3% 24.7%
Colostrum 10 126 7.9% 4.4% 14.0%
Fetus 30 515 5.8% 4.1% 8.2%
Muscle 8 167 4.8% 2.4% 9.2%
Milk 99 2091 4.7% 3.9% 5.7%
Mammary Gland flush fluid 0 7 0.0% 0.0% 35.4%




3.3.2.1 MAP prevalence in tissues 
 
For all tissues and animals tested the overall prevalence of MAP tissue contamination was 
10.2% [9.8% - 10.6%]. 
Regarding lymphoid tissue the overall prevalence was 7.6% [7.2% - 8.0%], while gastro-
intestinal lymphoid tissue was 5.9% [5.5% - 6.4%] and other lymphoid tissue                 
14.8% [13.5% - 16.2%]. 74% of lymphoid tissue samples belong to Ileocecal LN. 
The gastro-intestinal tract had an overall prevalence of 10.0% [9.6% - 10.5%] while intestinal 
mucosa had 22.9% [21.3% - 25.5%]. In whole GI tract, 77% of samples belong to GI 
Lymphoid tissue.  
Semen was the “tissue/body fluid” with the highest prevalence 100% [43.8% - 100%] 
followed by the uterine flush fluid 75% [30.1% - 95.4%]. However, this was a consequence of 
the small number of samples tested as it is demonstrated by the amplitude of the confidence 
interval. If sample size consists of a minimum of 100 animals sampled, then the tissues with 
highest prevalence rates were the hepatic LN (42.5% [36.2% - 49.1%]), the cecum mucosa 
(33.1% [25.3% - 41.8%]), the ileocecal valve mucosa (30% [25.7% - 34.7%]) and the jejunal 
mucosa (29.5% [23.4% - 36.5%]). 
The tissues that had most samples analyzed were ileocecal LN (10757 samples; prevalence 
4.1% [3.7% - 4.4%]), milk (2091 samples; prevalence 4.7% [3.9% - 5.7%]), ileum mucosa 
(1272 samples; prevalence 12.6% [10.9% - 14.5%]) and liver (798 samples; prevalence  
6.8% [5.2% - 8.7%]).  
The tissues with most positive samples were the ileocecal LN (436 positive samples; 
prevalence 4.1% [3.7% - 4.4%]), mesenteric LN (181 positive samples; prevalence       
29.3% [25.9% - 33.0%]) and ileum mucosa (160 positive samples; prevalence                        
12.6% [10.9% - 14.5%]). The last four mentioned tissues were also the most analyzed 
(between 12 and 16 studies).  
If we focus on animal body regions, 46% of the studies analyzed the gastro-intestinal tract 
(including gastro-intestinal lymph nodes), 54% non gastro-intestinal tissues and 42% the 
lymphoid tissue (including gastro-intestinal lymph nodes).  
Only two studies (Alonso-Hearn et al., 2009; Antognoli et al., 2008) analyzed muscle tissue. 
In the first only diaphragm muscle was tested, in the second three different muscles were 
analyzed but MAP was only isolated on heart. MAP contamination prevalence was          
4.8% [2.4% - 9.2 %].  
Milk contamination was found in 4.7% [3.9% - 5.7%] of samples studied (10 studies). 
The information relative to age and husbandry type was also collected in order to try to find 
an association between these factors and the presence of MAP in specific tissues. The 
statistical analyses were made but it was not possible to take any conclusion due to the 





Since the first description of paratuberculosis, Mycobacterium avium subspecies 
paratuberculosis organisms have been isolated from several tissues, faeces and body fluids. 
Initially, only suspected animals with clinical symptoms were tested but with the knowledge of 
the subclinical stage of infection, attempts have been made to look for MAP organisms in 
tissues of animals not showing disease characteristic clinical signs. 
MAP isolation has been used to prove MAP localization in a specific tissue, to confirm the 
result of other diagnostic tests for paratuberculosis or even to estimate the disease 
prevalence in a population. Recently, MAP isolation has been used to evaluate its 
occurrence in tissues bearing in mind a possible link between paratuberculosis and Crohn’s 
disease. 
 
In this work some studies with results about MAP isolation in tissues were used. Comparison 
of the results need to be made with caution, because they came from studies published in 
the last eight decades, in different populations, using different methods of investigation the 
same problem and with different strains of MAP.  
Experimental infection studies were allowed in the inclusion criteria because they analyzed a 
variety of tissues that otherwise would be without any information. Moreover their influence 
on the global results is not relevant (if they were excluded it will not change significantly the 
result). Their inclusion can be criticized because they do not represent the reality and the 
infectious dose that animals were exposed may differ substantially of the dose in natural 
infection. 
 
Though PCR is a technique easier to perform and faster than culture, the studies that 
isolated MAP by PCR were not included because PCR detects residual DNA and dead 
organisms, not making any differentiation between viable and non viable organisms, and 
thus has a low specificity for detection of tissues not containing live MAP. 
On the other hand, there is the problem of the possible existence of “paucibacillary forms” of 
infection, where the low number of the microorganisms may limit PCR techniques (Amemori 
et al., 2004). However, it can be a powerful tool if the PCR positive or PCR inconclusive 
tissues would then be submitted to a tissue culture for confirmation. 
 
In order to properly evaluate the MAP distribution in tissues, further studies are needed. 
Some aspects of the reviewed studies will be criticized and suggestions will be given that 
may guide further studies. 
To proceed with an epidemiological study the main objective must be specified. Regarding 
the possibility of MAP occurrence as a public health threat two types of studies should be 
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considered: pathogenesis study and prevalence study. In the former, an experimental study 
to assess MAP tissues susceptibility could be made. Guidelines for MAP experimental 
challenge models are described elsewhere (Hines II et al., 2007). On the other hand, an 
investigation of a well characterized population of naturally infected animals (with or without 
clinical signs, with positive or negative diagnostic tests), based upon a rigorous sanitary 
inspection and the collection of tissue samples could be a very fruitful option.   
With a better understanding of the host susceptibility, distribution and degree of 
contamination of MAP in tissues, further searches for MAP in naturally infected animals could 
be more precise and cost-effective. From a risk manager point of view this information should 
be assessed by specific risk groups with the objective to implement specific measures to 
reduce the risk of a contaminated cattle product entering the food chain. 
  
Further studies suggestions 
 
Hereafter, the discussion will focus on relevant aspects of a study to assess MAP distribution 
in tissues in a risk assessment view. 
 
Population level - animal selection 
 
Some authors suggested that the distribution of MAP in tissues is dependent on the time of 
uptake (Momotani et al., 1988; Sigurdardottir, Press & Evensen, 2001) and on the host 
immune response (Stabel, 2000a; Bendixen, 1978). If we consider that MAP dissemination in 
animal tissues is dependent on the prevailing type of immune response and that these 
responses correspond to different stages of infection, then the distribution of MAP in tissues 
may be associated with the infection stages.  In the estimation of regional susceptibility of 
MAP in tissues, the stage of infection should be taken into account because sampling on 
different stages may produce different results. With these stage-specific results the best 
sampling sites could be investigated and recommended also by infection stages. Therefore, 
on a study to assess MAP distribution, the study population should be representative of the 
target population and it should include cattle in different stages of infection. To do a stratified 
sampling the animal population must be very well characterized and the distribution of 
animals by age, infected, infectious and affected animals must be available. For each of 
these statuses, the relation between the results of the diagnostic tests and the MAP 
distribution in tissues should be investigated. 
Some studies analyzed in this work tried to assess the relation between positive culture 
results and clinical status, husbandry type and age range. In early studies that confirmed the 
existence of MAP outside the gastro-intestinal tract, cattle were selected based on the 
existence of clinical signs or the shedding of the agent in faeces. This made the 
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disseminated infection appear to be a characteristic of a late-stage of infection (Whitlock & 
Buergelt, 1996; Huda & Jensen, 2003; Buergelt et al., 1978; Pavlik et al., 2000). However, 
recent studies report that this type of infection could also be found in asymptomatic animals 
(Antognoli et al., 2008; Brady et al., 2008).  
Approximately 10.8% [9.71% - 11.92%] of the samples collected from affected animals were 
positive while asymptomatic animals had approximately 7.5% [7.14% - 7.93%] of their 
samples positive (P < 0.001). It was expected to observe a larger difference between groups. 
However, the proportion of samples collected by each group have to be considered 
(asymptomatic – 76.4%, affected – 13.5% of the collected samples). It was not possible to 
assess the proportion of infected animals by clinical status neither the proportion of infected 
animals with positive cultures, because the majority of animals were selected based on 
previous infection demonstration. 
Two studies evaluated the effect of the husbandry type. Merkal et al (1987) observed a 
significant difference of prevalence between husbandry types of 2.9% for dairy cattle and 
0.8% for beef cattle (difference 2.1% ± 0.35%). Pavlik et al (2000) estimated prevalence of 
dairy cattle were 44.9%, in beef cattle 31.1% and in dual-purpose cattle 29.0%. Both 
research teams attributed these differences to the differences in the management system. In 
our study it was not possible to assess the association between husbandry type and positive 
culture results for each tissue due to different study designs. However, the proportion of 
positive samples on dairy herds 13% and on beef herds was only 2% (P < 0.001). These 
values are in agreement with the findings of Merkal et al (1987) and Pavlik et al (2000). 
These differences are likely to reflect environmental disease determinants that increase the 
odds of infection, rather than an intrinsic host predisposition to contain MAP in a certain 
tissue. If this relation should be evaluated, the sampled animals should represent the 
distribution of each husbandry type on the concerned population. 
Some studies evaluated the factor age as a resistance or a susceptibility to infection. 
However, the studies that evaluated MAP distribution in tissues did not explore the age 
influence on the probability of MAP occurring in certain tissues. Age may be a factor of major 
importance and further studies are needed not only to improve the understanding of the 
relation between age and susceptibility to infection but also the relation between specific age 






Animal level – tissue selection 
 
Despite the variety of the objectives in the reviewed studies, all isolated MAP on a specific 
tissue. As expected by the date range of the publications, the methodology of cultivation, 
isolation and identification of the organism varied between studies.  
The objective of each study determined which tissues were collected. While some authors 
limited the tissue analysis to the gastro-intestinal tract (routine method), others collected also 
extra-gastrointestinal tissues (intensive method).  
The choice of the tissues to be collected should be based on the distribution of MAP 
infection, which is not completely understood. In fact some aspects need further clarification, 
for example: (i) which tissues outside the gastro-intestinal tract have more probability of 
being infected, (ii) the time of infection when these tissues become infected and (iii) how the 
organism disseminates inside the host. 
 
Regarding the nature of clinical signs and the present knowledge of the disease, the gastro-
intestinal tract was the region most studied for MAP isolation in tissues: 31 in 48 studies, 
12753 in 15004 animals, and 19968 in 22485 samples collected. The majority of 
paratuberculosis lesions have been described in distal ileum and at the ileocecal valve 
(Buergelt et al., 1978), jejunum and ileum (Brady et al., 2008), and from the duodenum to the 
rectum (Taylor, 1953).  
Concerning MAP isolation, in the study from Pavlik et al (2000), where distribution of MAP in 
the tissues collected was compared, the probability of detection of MAP infection in gastro-
intestinal related tissues was 90%. In Amemori et al (2004)13 distribution of MAP in intestinal 
mucosa and its associated LN was studied thoroughly. They calculated a positive culture 
proportion and suggested that the best gastro-intestinal related places to detect MAP were 
between jejunum mucosa to ileocecal-valve, and the distal jejunal LN, the proximal ileum LN 
and the cecum LN. Observing our results, 70% of the positives cultures from gastro-intestinal 
tract were included in the regions between jejunum and cecum (though, these regions 
correspond also to 91% of all analyzed). In addition, Peyer’s patches had been described as 
the “entry portal” for the agent (Momotani et al., 1988) and are distributed over the jejunum 
and the ileum (Landsverk et al., 1991). Regarding these arguments, in the case of a selective 
sampling of gastro-intestinal tissues, the mucosa and the associated lymph nodes from 
jejunum to cecum should be considered the key sampling sites. 
 
                                                
13 Study not included in the analysis because the authors haven’t expressed the results as required in the inclusion criteria. 63 
animals older than 2 years were analyzed, selected at slaughter, positive by fecal culture between 1995 and 2000. 890 samples 




Although there is no detailed description of MAP dissemination mechanism in tissues outside 
gastro-intestinal tract, the existence of a sporadic bacteraemia has been suggested. Some 
authors demonstrated MAP in the mononuclear cell-rich fraction of blood and in several 
tissue fluids (Koenig et al., 1993; Barrington et al., 2003; Buergelt & Williams, 2004; van der 
Giessen et al., 1995)14. It has also been shown that infected macrophages may not have 
effective intracellular killing mechanisms and that acid-fast bacilli may be carried to distant 
sites by blood-borne or lymph-borne mononuclear phagocytes (Bendixen, Bloch & 
Jorgensen, 1981). The access of MAP to the circulation can be via draining lymphatics, 
contiguous lymph nodes, thoracic duct or by direct invasion of blood vessels (Bendixen et al., 
1981). 
 
Several authors isolated MAP from non-gastrointestinal tissues (Annex 1), but only few 
studies researched the relation between disseminated and gastro-intestinal infection. Pavlik 
et al (2000) observed that when the infection was detected in parenchymatous organs (10% 
probability of detection) it was also detected in gastro-intestinal tract. Antognoli et al (2008) 
found disseminated infection in 21/28 (75%) and gastro-intestinal infection in 7/28 (25%) of 
the infected animals (28/40). Within the animals with disseminated infection, the liver (10/21) 
and the hepatic LN (17/21) were the tissues where MAP was most isolated.  
According to our analysis (Table 4 and Table 5), the tissues outside the gastro-intestinal tract 
where MAP was most isolated were: hepatic LN, mediastinal LN, supramammary LN, lung, 
spleen, uterus and prescapular LN. Milk should also deserve special attention because it is 
one of the animal products most consumed by humans and the assessed prevalence was 
4.7% [3.9% - 5.7%]. 
 
There is little knowledge about MAP excretion in milk of infected cows (Sweeney et al., 
1992a) such as shedding quantities, timing of the beginning of milk shedding or the dynamics 
of MAP shedding in milk (continuous or intermittent). If an intermittent shedding exists it may 
be an obstacle to MAP detection by faecal culture like it happens on faeces. Another point to 
bear in mind is the time between the beginning of shedding in milk and the time of MAP 
detection. If milk is commercialized before milk culture result is known, MAP may enter the 
food chain. If the relation between faecal excretion, antibody production and MAP shedding 
in milk is understood, precautionary measures could be implemented regarding the milk 
collection of infectious animals. 
Another way to address this problem was adopted by the Dutch Milk Quality Assurance 
Programme. A programme to analyze and to reduce bulk milk tank MAP concentration 
                                                
14 The studies from van der Giessen et al (1995), Barrington et al (2003) were not included in the analysis because MAP 




instead of an individual animal approach is on use. They considered that the major cause for 
MAP occurrence in milk is faecal contamination rather than individual excretion, due to the 
huge quantities of viable MAP on faeces (Weber, Nielen, Velthuis & van Roermund, 2008). 
 
Regarding muscle, Antognoli et al (2008) and Alonso-Hearn et al (2009) were the only ones 
to search for the presence of MAP in this tissue. Muscle tissue is very important because 
together with milk it is the main bovine product consumed by humans. To our knowledge, the 
mechanism of dissemination of MAP from gastro-intestinal sites to muscle, the timing of 
muscle infection, MAP quantities and specific muscle susceptibility are unknown. When 
assessing the prevalence of MAP organisms in muscle, the results should be stratified by 
infection stage and obtained from a very well characterized population. It would also be 
interesting to evaluate the relation between MAP existence in muscles and the animal clinical 
condition (assessing the most important clinical signs, the capacity of detecting them and 
culling the animal), husbandry type, age range and the presence of gross lesions. With this 
information, the risk could not only be assessed regarding the status of the animal confirmed 
by laboratory tests, but also by observable factors in the slaughterhouse. 
 
Relation between macroscopic lesions and MAP isolation 
 
An association between existence of Paratuberculosis macroscopic lesions and the isolation 
of MAP organisms was established by several authors (Brady et al., 2008; Amemori et al., 
2004; Dennis et al., 2008). Though tissues should be investigated for the presence of 
macroscopic lesions, as their existence depends on several factors and they are more likely 
to occur on advanced stages of the disease, they are not sufficiently specific to confirm 
paratuberculosis infection (González et al., 2005; Amemori et al., 2004; Dennis et al., 2008; 
Buergelt et al., 1978). The existence of focal, multifocal and diffuse forms of lesions together 
with the possibility of MAP existence on tissues without lesions should be considered when 
deciding the number of samples collected per tissue. However, the relation between 
observable MAP gross lesions in gastro-intestinal tract and MAP dissemination to other 
tissues has not yet been studied. If there is a relation this information could be used at 
slaughterhouse environment. The non clinical animals accepted in ante mortem inspection 
but showing gross lesions could be detected and rejected in post mortem inspection. 
Inspector capacity of detecting infected cattle, non-clinical but with gross lesions animals 








Regarding the possibility of cross-contamination between tissues, tissues and materials, and 
faecal contamination, some precautions must be taken during sample collection. An aseptic 
technique should be preferred (tissues that have more probability of being contaminated 
should be collected last; materials used should be sterilized between tissues). If the 
collection is made at a slaughterhouse several aspects should be taken into account: the 
knowledge of cattle anatomy and aseptic techniques for sample collection, of the person in 
charge of collection (a veterinary should be preferred), and the abattoir line time (it should 




The resistance of MAP to adverse conditions is known, however, no published studies 
demonstrate the effect of tissue freezing on MAP recovering by tissue culture (Hines II et al., 
2007). This aspect should be investigated. Important aspects such as decontamination, 
isolation, identification, confirmation and quantification methods have been described by 
some authors (Hines II et al., 2007; Whittington, 2009) 
In our analysis, MAP was isolated by the recent and oldest laboratory techniques. This 




The results should be presented by number of positives and/or quantification/concentration 
of organisms, and number of tissues sampled. If several samples are made on the same 
tissue in the same animal and give different results, the final result of the tissue (positive or 
negative) should be reported. All results should be specified by groups analyzed (by age, by 








Though the relation between Crohn’s Disease in humans and MAP in cattle remains unclear 
(Waddell et al., 2008), based on the precautionary principle, it is important to improve the 
understanding of the MAP occurrence on tissues that may enter into the food chain. Although 
several authors isolated MAP by culture on a diversity of tissues, to our knowledge, a study 
with the aim of identifying the probability of MAP occurrence and quantification on cattle 
tissues, on a representative sample, has not been done. 
 
During the analysis of the different methodologies used by different studies, problems with 
sampling and MAP recovery were found. Due to the chronic characteristics of the disease 
and the lack of sensitivity and specificity of the diagnostic tests, the characterization of an 
animal population regarding each animal stage of infection is a very hard task. However, this 
information is needed to make some recommendations from a risk management point of 
view, both to reduce MAP dissemination on tissues and to reduce the presence of MAP 
contaminated tissues in food products. Regarding MAP isolation methods, the tissue culture 
was preferred rather than PCR techniques since the former is the only method that allows for 
the identification of viable and cultivable forms of the organism (which could be an important 
factor if a relation between diseases is confirmed). However, tissue culture also has some 
drawbacks: it is a slow process; it may give false positives results; and MAP quantification is 
hampered by MAP propensity to clump. Hence, when the most probable tissues 
contaminated with MAP will be known, PCR techniques will be used, as fast and highly 
sensitive methods to exclude MAP-infected tissues from the food chain. 
 
The results of our work could not be used to point the likelihood of each tissue to contain 
MAP due to limitations discussed previously. However, our results could be use to set 
priorities on the choice of tissues to be sampled on future studies to assess MAP distribution 
on tissues. The statistics of tissues more consumed by humans is another way to establish 
priorities for tissue’s study. On the other hand, we found that few studies investigated the 
existence of MAP on muscle and milk by tissue culture. Regarding frequency of consumption 
of these tissues they should be targeted on future investigations. 
 
After the characterization of the occurrence and the quantification of MAP on tissues, a 
further step should be the development of ante mortem diagnostic tests to identify live 
animals with MAP on tissues that will be consumed by humans. With this knowledge, cattle 
could be defined as infectious not only regarding their potential for disease transmission to 
other animals (like they are by MAP in faeces or colostrum), but also because of their 
potential hazard to humans. At slaughterhouses could also be interesting to have a test for 
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MAP detection on specific tissues in order to approve or reject carcasses. Another approach 
would be to reject certain tissues from high risk animals. 
 
Briefly, further studies are needed to characterize by infection stage the occurrence of MAP 
on animal tissues, bearing in mind the possible link between Crohn’s Disease and MAP, as a 
potential food safety hazard to consumers.  
 
3.5.1 Study results 
Hereafter our study results will be briefly summarized. 
 
3.5.1.1 Previous studies on MAP tissue culture isolation 
The studies where MAP was isolated by tissue culture that fit the inclusion criteria 
are assembled on Table 2 and Table 3. 
 The tissues where MAP was most investigated were: 
o Ileocecal LN – 16 studies; 
o Mesenteric LN and  Ileum mucosa – 14 studies; 
o Liver – 12 studies; 
o Mediastinal LN, Hepatic LN, Spleen and Milk – 10 studies. 
 Tissue which further investigation is required: 
o Muscle – 2 studies; 
o Milk – 10 studies;  
o Other tissues commonly consumed by humans. 
 
3.5.1.2 MAP prevalence in tissues 
The prevalence of MAP tissue contamination estimated in our study is summarized 
on Table 4 and Table 5.  
 On our literature review MAP was found in: 
o Intestinal mucosa; 
o Gastro-intestinal lymph nodes;  
o Head lymph nodes;  
o Thoracic and abdominal lymph nodes;  
o Lung, spleen, kidney and liver;  
o Genitor-urinary tract tissues; 
o Other “tissues/body fluids” such as semen, plasma, colostrum, milk, 
mammary gland flush fluid, collection chamber flush fluid, uterine flush fluid, 
mammary gland, foetus, pharynx and muscle. 
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 Tissues where MAP was most frequently isolated15: 
o Intestinal mucosa: cecum, ileocecal valve and jejunum; 
o Gastro-intestinal lymphoid tissue: mesenteric LN, cecal LN and ileocecal 
LN; 
o Head lymphoid tissue: retropharyngeal LN and tonsil; 
o Other LN: hepatic LN, mediastinal LN and supramammary LN; 
o Internal organs: lung, spleen and liver; 
o Genitourinary tract: uterus; 
o Other tissues: colostrum, foetus, muscle and milk. 
 Tissues frequently consumed by humans where MAP was most isolated: 
o Milk – 4.7% [3.9% – 5.7%]; 
o Muscle – 4.8% [2.4% - 9.2%]. 
 
3.5.2 Study limitations 
Our study and results have several limitations and drawbacks that are briefly 
described below: 
 Manual and electronic literature search instead of a systematic literature review 
approach; 
 MAP isolation only by tissue culture instead of PCR; 
 MAP tissue prevalence was assessed irrespective of cattle infection status; 
 MAP prevalence may not be representative and it should not be compared 
between tissues due to different study designs and methodologies. 
 
3.5.3 Knowledge gaps of MAP distribution in tissues  
After the literature revision several knowledge gaps and lacks of information were 
found: 
 Detailed mechanism of MAP distribution and tissues colonization; 
 Relation between paratuberculosis symptoms and MAP disseminated infection; 
 Relation between diagnostic test results and MAP distribution in tissues; 
 Relation between observable MAP gross lesions and the degree of MAP 
dissemination; 
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Bacteria establish in gut
Immune response with control
Destruction of gut tissue
Immune response without control
 
 
Fig. 5 – Schematic representation of pathogenesis of MAP infection and Clinical Signs, Gross Lesions, Histopathological Lesions, Humoral and Cellular Immune 
Responses, Bacterial Shedding and MAP dissemination to tissues. The point in time when the event pass from “Low” to “Minor” is not well known. Regarding the 
immune responses, the point in time when a cellular immune response shift to a humoral immune response is unknown. The relation between MAP dissemination to 
tissues and the previous columns need further investigation. 
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3.5.4 Future research 
 
Regarding our study limitations and the current scientific knowledge gaps founded some 
further approaches are proposed: 
 
 A MAP distribution in tissues assessment study: 
o Study population: 
 Should be representative of the target population; 
 Should include cattle on different stages of infection. 
 
o Key sampling sites to detect MAP infection16: 
 Gastro-intestinal tissues: mucosa and associated lymph nodes from 
region between jejunum and cecum; 
 Non gastro-intestinal tissues17: hepatic LN, retropharyngeal LN, 
mediastinal LN, supramammary LN, lung, spleen, uterus. 
 
o Cross-contamination precautions: 
 Aseptic technique: 
 Highly contaminated tissues should be collected last; 
 Sterilization of materials between collecting procedures; 
 Staff training on sample collecting procedures, animal anatomy 
and aseptic techniques. 
 
 Further studies needed: 
o To make available the mentioned knowledge gaps; 








                                                
16 To assess MAP distribution in tissues, key sampling sites are dependent on study objectives. 




4 Risk assessment conceptual model 
 
Risk analysis is a process constituted by 4 components: hazard identification, risk 
assessment, risk management and risk communication (Anon, 2004a; Anon, 2007). 
Risk assessment is used to estimate, to evaluate, to discuss and to document the risk of an 
adverse event as well as its mitigation (Anon, 2004a). As referred above, in order to better 
understand the possibility of MAP sources to humans, a release assessment should be 
done. The release assessment, in The World Organisation for Animal Health (OIE) 
terminology, describes the biological pathways necessary to understand the problem, to 
identify the parameters involved and to define how parameters are interrelated. 
 
4.1 Hazard Identification 
 
Regarding the purpose of this risk assessment the hazard considered is the Mycobacterium 
avium subspecies paratuberculosis (MAP) despite the absence of an irrefutable causal 
relationship between MAP and Crohn’s Disease. The characteristics and details about MAP 
and MAP infection were already described before in this dissertation. 
 
4.2 Release Assessment 
 
At the starting point of a risk assessment, the risk question is formulated. In our specific 
case, the risk question is: “What is the probability of occurrence of MAP on unprocessed 
beef and milk from specific cattle risk groups?”. To address this question a risk model 
pathway should be designed and the likelihood and the quantity of MAP should be estimated 
afterwards. Two risk model pathways will be described: one for milk and other for muscle 
tissue. For each one, the assumptions, the required data and the data knowledge gaps will 
be pointed out. 
 
4.3 Risk model pathway – Milk 
 
The isolation of MAP from aseptically collected milk samples means that infected milking 
cows can shed MAP in their milk (Alexejeff-Goloff, 1929; Streeter et al., 1995; Sweeney et 
al., 1992a; Taylor et al., 1981). Despite some authors studied the mechanism of MAP 
infection in the gastro-intestinal tract, the way MAP spread within the host and its relation 
with different stages of infection remains unclear. Thus, the mechanism of MAP shedding is 
not fully understood (Sweeney et al., 1992a). However it may be dependent on animal 
characteristics and its stage of infection. Regarding this assumption, the information required 
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to assess the likelihood and the quantity of MAP presence on unprocessed milk is under 
mentioned. To use stochastic models in the risk assessment these data should be available 
by distributions instead of point estimates. 
 
In order to assess the likelihood and the quantity of MAP on milk, the processes that allow 
MAP from an infected dairy cow to occur in the individual milk should be evaluated.  As this 
is a risk model pathway for a release assessment the end-point considered will be the cow’s 
individual milk. In the design of this pathway some assumptions were made:  
 The existence of a ParaTB control programme. The characteristics of the Danish 
control programme were used; 
 Only dairy herds provide milk for human consumption; 
 Only animals ≥ 2 years old provide milk for human consumption (assumption made 
based on the normal low proportion of animals < 2 years that provide milk and their 
unlikely shedding of MAP organisms in milk); 
 MAP shedding in milk is dependent on animal characteristics and stage of infection; 
 Regarding the herds not in the ParaTB Programme it is considered that the animals 
aren’t systematically tested, therefore, there is a lack of information regarding the 
herd and animal status. The between-herd and within-herd true prevalences and the 
probability of MAP dissemination to milk could be theoretical and literature-based 
values; 
 Herds included in the ParaTB Programme have measures implemented to reduce 
paratuberculosis prevalence, therefore the probability of be an infected herd and have 
infected animals is different from the herds not in the ParaTB Programme;  
 Within a herd in the ParaTB Programme there is always the possibility of existence of 
some non tested animals. They will be assumed as having the same distribution of 
risk groups as the tested animals considering that the reasons for non-testing would 
possibly be caused by in-herd practical questions and that they will not affect the 
intrinsic probability of MAP excretion in milk; 
 For a herd be considered Not Infected, a representative sample of herd’s animals 
must have been tested and give test negative results. Animals that had negative test 
results are considered non infected and consequently no MAP dissemination to milk 
occurs; 
 It is assumed that the test is made on individual milk instead on the bulk milk tank, the 
test positive results for MAP are considered a possible hazard to humans and the 
milk should be discarded not representing any risk. 
 






















































Fig. 7 – Milk risk model pathway part 2 – animal characteristics given that an infected herd gives test positive result. The dotted line represents the lack of data to 
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Fig. 8 – Milk risk model pathway part 2 – animal characteristics given that an infected herd gives test negative result. The dotted line represents the lack of data to 



































































Box name Description 
Herds in ParaTB Programme Due to thoroughly animal testing in a ParaTB Programme, information about Herd Infection and Test Status should be available 
for herds in the ParaTB Programme. The ParaTB prevalence will also be influence by the existence of the control programme. Herds not in ParaTB Programme 
Herd MAP infected Herd Infection Status. In a Non Infected Herd is considered that all animals are Not Infected and consequently there is No Risk 
of MAP occurring in Milk. Herd MAP not infected 
Herd MAP tested + 
Herd Test Status. An Infected Herd can be Test Positive or Negative regarding the test sensitivity. 
Herd MAP tested - 
Animal MAP Infected 
Animal Infected Status. In a Non Infected Animal there is No Risk of MAP occurring in Milk. 
Animal MAP not Infected 
Animal MAP tested + Animal Test Status.  An Infected Animal can be Test Positive or Negative regarding the test sensitivity. In a Non Infected Animal 
there is No Risk regardless the Animal Test result. Animal MAP tested - 
Red 
Animal test results characterization representing the different animal infection stages. Colour scheme used in the Danish ParaTB 
Programme regardless the lack of knowledge regarding the relation between antibody profile and MAP dissemination to Milk. 
Yellow 
Green 
MAP disseminated to Milk MAP occurrence in Milk by MAP dissemination to milk in an infected animal. This MAP occurrence should be related with the 
animal infection stage and the programme colour scheme. If MAP has not disseminated to milk there is No risk regardless the 
Milk test result. MAP not disseminated to Milk 
Milk MAP tested + Milk Test Status for the MAP occurrence.  Milk where MAP dissemination has occurred can be MAP Test Positive or Negative 
regarding the test sensitivity. A milk MAP tested positive may be considered as No Risk if this milk is discarded not entering the 
food chain. Milk MAP tested - 
Pathway Equal Above Above pathway repeats. 




Table 7 - Milk risk model pathway description: list of variables and data availability. 
 
Variable Variable description Comments Availability 
P1 Probability of a herd be MAP Infected 
Between-herd true prevalence for the herds in the ParaTB Programme. The measures 
implemented due to the existence of a ParaTB Programme will influence this prevalence. 
Data available for 
Denmark 
(but only apparent 
prevalence) 
1 – P1 Probability of a herd be MAP not Infected 
P2 Probability of an animal be MAP Infected 
Within-herd true prevalence. Data available 
1 – P2 Probability of an animal be MAP not Infected 
P3 Probability of MAP dissemination to milk Prevalence of MAP occurrence in milk by MAP dissemination to milk. This information should 
be related with animal infection stage. To our knowledge this information is not currently 
available. 
Not available 
1 – P3 Probability of MAP non dissemination to milk 
Q1 
Quantity of MAP occurrence in milk by MAP dissemination to 
milk 
Quantity of MAP occurrence in milk by MAP dissemination to milk.  This information should 
be related with animal infection stage. To our knowledge this information is not currently 
available. 
Not available 
PT-BHTP Probability of a herd be MAP Infected Theoretical between-herd true prevalence for the herds not in the ParaTB Programme (could 
be literature-based). 
Data available 
1- PT-BHTP Probability of a herd be MAP not Infected 
PT-WHTP Probability of an animal be MAP Infected Theoretical within-herd true prevalence for the herds not in the ParaTB Programme (could be 
literature-based). 
Data available 
1- PT-WHTP Probability of an animal be MAP not Infected 
PT-MMD Probability of MAP dissemination to milk Theoretical prevalence of MAP occurrence in milk by MAP dissemination to milk (could be 
literature-based). 
Not available 
1- PT-MMD Probability of MAP non dissemination to milk 
QT 
Quantity of MAP occurrence in milk by MAP dissemination to 
milk 




Herd sensitivity of the test used An Infected Herd can be considered Test positive or negative regarding the test sensitivity. Data available 
1 – HSe 
Se 
Sensitivity of the test used An Animal or Milk can be considered Test positive or negative regarding the test sensitivity. Data available 
1 – Se 
PrinPr Proportion of herds in the ParaTB Programme It is important to make this differentiation because it will influence the ParaTB prevalence 
and the available information about infection and test status of the “herd”, “animal” and 
“milk”. 
Data available 
PrnotPr Proportion of herds not in the ParaTB Programme 
PrG Proportion of cows in the Green risk group It is important to make this differentiation because different proportions of risk groups will 
influence the final MAP occurrence in Milk. Colour scheme used in the Danish ParaTB 
Programme regardless the lack of knowledge regarding the relation between antibody profile 
and MAP dissemination to Milk. 
Data available PrY Proportion of cows in the Yellow risk group 
PrR Proportion of cows in the Red risk group 
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4.3.1 Data availability and risk description 
 
Data availability 
Most information about the herd and the animal characteristics should be available on the 
databases of the ParaTB control programme. However, in the case of the Danish ParaTB 
control programme not all information is available with the detail proposed by this risk model 
pathway: 
 Only herds in the ParaTB programme have information about the herd and animal 
infection and test status. This information for herds not in the ParaTB programme is 
not available. 
 The allocation of animals into different risk groups is based upon animal’s milk 
antibody profile. To our knowledge, the mechanism of MAP dissemination to udder is 
not understood so the relation between the degree and quantity of MAP 
dissemination to milk and the antibody response is unknown. Then there is no data 
available for the different probabilities and quantity of MAP excretion on milk by 
different risk groups. 
 
Risk description 
In the context of this risk model pathway it is assumed that there is no risk to MAP entering 
the food chain when herds, animals and milk are considered not infected and when milk is 
considered infected, test positive and discarded not entering the food chain. 
There is risk of MAP entering the food chain in the specific case of infected herds not in the 
ParaTB Programme (because there are infected animals that could be excreting MAP into 
milk and this information is not available) and in milk where MAP excretion had occurred and 
gives test negative result. 
 
In this risk model pathway all information is about cow’s individual milk. If the bulk tank milk 
should be considered it will be important to differentiate a scenario where milk is grouped by 
risk groups or a scenario of no separation between risk groups with all milk being mixed in 
the bulk tank. Regarding the actual Danish ParaTB Programme, because there aren’t 
measures implemented considering MAP as a hazard to humans, all milk is entering the food 
chain despite the cow’s risk group. In the scenario where there is no separation of the milk 
produced by different risk groups, their individual probabilities should be added and the 
proportion of cows on each risk group will affect the final probability and quantity of MAP 
occurrence in the bulk tank milk. Regarding MAP quantity and considering all milk mixed in 




The MAP quantities in faeces and the probability of faecal contamination during milk 
collection are other important aspects, related with milking hygiene routines and milk 
collection, but are out of the scope of this work. However, in order to evaluate the MAP 
added to milk by faecal contamination two values must be known: the quantity of faeces that 
may contaminate the milk during milk collection and the quantity of MAP in this amount of 
faeces regarding the distribution of risk groups of animals on the herd. 
 
Depending on the objectives of the risk assessment and of the scope of the risk question, 
units to each parameter should be assigned. For example, the evaluation of each probability 
and MAP quantity could be made by litre of milk. 
 
As an example, the final probability of MAP occurrence on milk MAP test negative, from 
infected cows, in the Red risk group, from herds MAP test positive would be the product of: 
the proportion of herds in the ParaTB programme; the probability of the herd be MAP 
infected; the herd sensitivity of the test; the probability of the animal be MAP infected; the 
sensitivity of the test used; the proportion of cows in the Red risk group; the probability of 
MAP dissemination to milk in cows of the Red risk group and the (1 – sensitivity) of the test 
used. In this scenario the final risk would also consider the quantity of MAP excreted by this 







4.4 Risk model pathway – Muscle 
 
Regarding MAP presence on muscle tissue, in the literature search described previously, 
only two articles were found (Alonso-Hearn et al., 2009; Antognoli et al., 2008). In the first 
study diaphragm muscles were investigated (6 positive animals in 47 animals). In Antognoli 
et al. (2008) only three muscles were investigated: heart muscle (2 positives in 40 animals), 
Longissimus colli (0/40) and Extensor carpi radialis (0/40). As mentioned for the milk model 
pathway, MAP spreading throughout the host and its relation with different stages of infection 
is unknown. The same applies to the probability of MAP occurrence and the quantity of MAP 
on muscle. 
To assess the likelihood and the quantity of MAP in muscle, the factors that influence MAP 
presence in muscle of slaughtered cattle should be analyzed. Thus the end-point of the 
release assessment will be the muscle tissue at the end of the slaughter line – unprocessed 
beef. In the construction of this pathway some assumptions were made:  
 The existence of a ParaTB control programme. In this case the characteristics of 
Danish control programme will be used, however, the Danish Paratuberculosis 
Programme was designed for Dairy cattle only; 
 The characteristics of Danish milk testing scheme and risk group’s colours will be 
used to differentiate risk groups in cattle ≥ 2 years old from Dairy herds. Another 
hypothetical differentiation in risk groups (High/Medium/Low) will be used for non 
dairy cattle and dairy cattle < 2 years old (not providing milk). These risk groups could 
be assessed using other diagnostic test more suitable to these specific animals; 
 Dairy and non dairy herds provide beef for human consumption; 
 MAP presence in muscle is dependent on animal characteristics and their stage of 
infection; 
 Regarding the herds not in the ParaTB Programme it is considered that the animals 
aren’t systematically tested, therefore, there is lack of information regarding the herd 
and animal status. The between-herd and within-herd true prevalences and the 
probability of MAP dissemination to milk could be theoretical literature-based values; 
 Herds included in the ParaTB Programme have measures implemented to reduce 
paratuberculosis prevalence, therefore the probability of be an infected herd and have 
infected animals is different from the herds not in the ParaTB Programme;  
 Within a herd in the ParaTB Programme there is always the possibility of existence of 
some non tested animals. They will be assumed as having the same distribution of 
risk groups as the tested animals considering that the reasons for non-testing would 
possibly be caused by in-herd practical questions and that they will not affect the 
intrinsic probability of MAP dissemination to muscle; 
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 For a herd be considered not infected, a representative sample of herd’s animals 
must have been tested and give test negative results. Animals that had negative test 
results are considered non infected and consequently no MAP dissemination to 
muscle occurs; 
 It is assumed that an animal in the Red risk group or in the High risk group showing 
clinical signs at the ante mortem inspection will be rejected not representing any risk. 
 It is assumed that muscle tested positive results for MAP are considered a possible 
hazard to humans and the muscle should be rejected not representing any risk. 
 













Fig. 9 - Muscle risk model pathway part 1 - herd characteristics. 
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Fig. 14 – Muscle risk model pathway part 3 – animal characteristics given that a Red or High risk group animal (from dairy herd) - observable factors that could be 
investigated at slaughterhouse environment. It is assumed that an animal in the Red risk group or in the High risk group showing clinical signs at the ante mortem 









































Fig. 15 – Muscle risk model pathway part 3 – animal characteristics given that a Yellow/Green or 
Medium/Low risk group animal (from dairy herd) - observable factors that could be investigated at 
slaughterhouse environment. The dotted line represents the lack of data to support the relation 














































































Fig. 10 & 11
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Fig. 16 – Muscle risk model pathway part 3 – animal characteristics given that a High risk group animal (from non-dairy herd) - observable factors that could be 
investigated at slaughterhouse environment. It is assumed that an animal in the High risk group showing clinical signs at the ante mortem inspection will be rejected. 















































Fig. 17 – Muscle risk model pathway part 3 – animal characteristics given that a Medium/Low risk 
group animal (from non-dairy herd) - observable factors that could be investigated at slaughterhouse 
environment. The dotted line represents the lack of data to support the relation between MAP 
























































































Herds in ParaTB Programme Due to thoroughly Animal testing in a ParaTB Programme, information about Herd Infection and Test Status should be available for herds in the ParaTB Programme. 
The ParaTB prevalence will also be influence by the existence of the control programme. Herds not in ParaTB Programme 
Dairy Herd / Non Dairy Herd Considering differences in the animal management system the further steps should be assessed separately for Dairy/Non Dairy herds. 
Herd MAP infected 
Herd Infection Status. In a Non Infected Herd is considered that all animals are Not Infected and consequently there is No Risk of MAP occurring in muscle. 
Herd MAP not infected 
Herd MAP tested + Herd Test Status. An Infected Herd can be Test Positive or Negative regarding the Test Sensitivity. In a Non Infected Herd there is No Risk regardless the Herd Test 
result. Herd MAP tested - 
Animal MAP Infected 
Animal Infected Status. In a Non Infected Animal there is No Risk of MAP occurring in muscle. 
Animal MAP not Infected 
Animal MAP tested + Animal Test Status.  An Infected Animal can be Test Positive or Negative regarding the Test Sensitivity. In a Non Infected Animal there is No Risk regardless the 
Animal Test result. Animal MAP tested - 
Red / High Animal test results characterization representing the different animal infection stages. Colour scheme is used in the Danish ParaTB Programme. The characteristics of 
Danish milk testing scheme and risk group’s colours will be used to differentiate risk groups in cattle ≥ 2 years old from Dairy herds. Another hypothetical differentiation 
in risk groups (High/Medium/Low) will be used for non dairy cattle and dairy cattle < 2 years old (not providing milk). These risk groups could be assessed with other 
diagnostic test more suitable to these specific animals 
Yellow / Medium 
Green / Low 
Animals ≥ 2 years / < 2 years 
Since MAP infection is age-related the risk should be assessed by age groups (Animals with or older than 2 years and animals younger than 2 years).  On the other 
hand, the quantities of beef produced by these age groups are different so it will be relevant to know which group poses a higher risk. 
Clinical / Non Clinical If a relation between MAP dissemination to muscle and clinical signs if found, risk should be assessed separately regarding expression/non expression of clinical signs. 
Clinical Accepted / Rejected 
Considering a relation between MAP dissemination to muscle and clinical signs, and the existence of specific clinical signs representing MAP dissemination to muscle, 
animals could be rejected at the ante mortem inspection at the slaughterhouse and be considered as No Risk. 
Observable Gross Lesions If a relation between MAP dissemination to muscle and post mortem observable gross lesions if found, risk should be assessed separately regarding the existence of 
observable/non observable gross lesions. Non Observable Gross Lesions 
Carcass Accepted / Rejected 
Considering a relation between MAP dissemination to muscle and observable gross lesions, and the existence of specific gross lesions representing MAP 
dissemination to muscle, carcasses could be rejected at the post mortem inspection at the slaughterhouse and be considered as No Risk. 
MAP disseminated to Muscle MAP occurrence in Muscle by MAP dissemination to muscle in an infected animal. This MAP occurrence should be related with all previous steps in the pathway. If 
MAP has not disseminated to muscle there is No risk regardless the Muscle test result. MAP not disseminated to Muscle 
Muscle MAP tested + Muscle Test Status for the MAP occurrence.  Muscle where MAP dissemination has occurred can be MAP Test Positive or Negative regarding the Test Sensitivity. A 
muscle MAP tested positive may be considered as No Risk if this muscle is discarded not entering the food chain. Muscle MAP tested - 
Pathway Equal Above Above pathway repeats. 




Table 9 - Muscle risk model pathway description: list of variables and data availability. 
 
Variable Name Comments Availability 
P1 Probability of a herd be MAP Infected Between-herd true prevalence for the herds in the ParaTB Programme. It should be available 
for the Dairy and Non Dairy herds. The measures implemented due to the existence of a 
ParaTB Programme will influence this prevalence. 
Data available for Denmark 
(but only apparent 
prevalence) 1 – P1 Probability of a herd be MAP not Infected 
P2 / 1 - P2 Probability of a herd be MAP Infected / not Infected Within-herd true prevalence. Data available 
P3 / 1 – P3 
Probability of MAP dissemination / non dissemination to 
muscle 
Prevalence of MAP occurrence in Muscle. This information should be related with animal 
infection stage. To our knowledge this information is not currently available. 
Not available 
Q1 
Quantity of MAP occurrence in muscle by MAP 
dissemination to muscle 
Quantity of MAP occurrence in milk by MAP dissemination to milk.  This information should 
be related with animal infection stage. 
Not available 
PT-BHTP / 1- PT-BHTP Probability of a herd be MAP Infected / not Infected 
Theoretical between-herd true prevalence for the herds not in the ParaTB Programme (could 
be literature-based). 
Data available 
PT-WHTP / 1- PT-WHTP Probability of an animal be MAP Infected / not Infected 
Theoretical within-herd true prevalence for the herds not in the ParaTB Programme (could be 
literature-based). 
Data available 
PT-MMD / 1- PT-MMD 
Probability of MAP dissemination / Non dissemination to 
muscle 




Quantity of MAP occurrence in muscle by MAP 
dissemination to muscle 
Theoretical quantity of MAP occurrence in muscle by MAP dissemination to muscle (could be 
literature-based). 
Not available 
HSe / (1 – HSe) Herd sensitivity of the test used An Infected Herd can be considered test positive or negative regarding the test sensitivity. Data available 
Se / (1 – Se) Sensitivity of the test used 
An Infected Animal or Muscle can be considered test positive or negative regarding the test 
sensitivity. 
Data available 
PrinPr Proportion of herds in the ParaTB Programme It is important to make this differentiation because it will influence the ParaTB prevalence 
and the available information about infection and test status of the “herd”, “animal” and 
“muscle”. 
Data available 
PrnotPr Proportion of herds not in the ParaTB Programme 
PrD / PrNonD Proportion of Dairy/Non Dairy herds ------ Data available 
PrG /  PrY  /  PrR Proportion of cows in the Green/Yellow/Red risk group 
It is important to make this differentiation because different proportions of risk groups will 
influence the final MAP occurrence in Muscle.  
 
For the variables PrObsGL/PrNonObsGL and PrCa / PrCr, the ones with number 1 correspond to 
animals expressing clinical signs and variables with number 2 to animals not expressing 
clinical signs. 
Data available PrL /  PrM  /  PrH Proportion of cows in the Low/Medium/High risk group 
Pr≥2 years / Pr<2 years Proportion of cows ≥ 2 years / < 2 years 
PrCl /  PrNon Cl 
Proportion of animals expressing/not expressing clinical 
signs 
Not Available 
PrCla / PrClr Proportion of animals that are clinical accepted /rejected 
PrObsGL/PrNonObsGL 
Proportion of animals with/without observable gross 
lesions 
PrCa / PrCr Proportion of carcasses accepted / rejected 
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4.4.1 Data availability and risk description 
 
Data availability 
Most information about the herd and the animal characteristics should be available on the 
databases of the ParaTB control programme. However, in the case of the Danish ParaTB 
control programme not all information is available with the detail proposed by this risk model 
pathway (also because it was the control programme was designed for dairy cattle only): 
 Only herds in the ParaTB programme have information about the herd and animal 
infection and test status. This information for herds not in the ParaTB programme is 
not available (theoretical literature-based values could be considered). 
 The allocation of animals into different risk groups is based upon animal’s milk 
antibody profile. To our knowledge, the mechanism of MAP dissemination to muscle 
is not understood so the relation between the degree and quantity of MAP 
dissemination to muscle and the antibody response is unknown. Then there is no 
data available for the different probabilities and quantity of MAP excretion on muscle 
by different risk groups.  
 The characteristics of Danish milk testing scheme and risk group’s colours were used 
to differentiate risk groups in cattle ≥ 2 years old from Dairy herds. Another 
hypothetical differentiation in risk groups (High/Medium/Low) was used for non dairy 
cattle and dairy cattle < 2 years old (not providing milk). These risk groups could be 
assessed with other diagnostic test more suitable to these specific animals. 
 The relation between the degree and quantity of MAP dissemination to muscle and 
age and other observable factors (clinical signs and gross lesions) at slaughterhouse 
environment is unknown. Then there is no data available for the different probabilities 
and quantity of MAP excretion on muscle by these different risk groups (e.g. by 
animals demonstrating clinical signs, being clinical accepted, demonstrating 
observable gross lesions and the carcass be accepted). 
 
Risk description 
In the context of this risk model pathway is assumed that don’t exist risk to MAP entering the 
food chain when herds, animals and muscle are considered Not Infected, when an infected 
animal or an animal from Red/High risk group and showing clinical signs is rejected at ante 
mortem inspection, when the carcass is rejected at the post mortem inspection, or when is 
considered that has occurred MAP dissemination to muscle, it was test positive and rejected 
not entering the food chain. There is risk of MAP entering the food chain in the specific case 
of infected herds not in the ParaTB Programme (because there are infected animals where 
MAP dissemination to muscle may have occurred and this information is not available) and 
when MAP dissemination to muscle has occurred and gave test negative result. 
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The MAP quantities in faeces and the probability of faecal contamination at the slaughter line 
are important aspects related with the hygiene procedures but are out of the scope of this 
work. However, in order to evaluate the MAP added to muscle by faecal contamination two 
values must be known: the quantity of faeces that contaminates muscle tissues at the 
slaughter line and the quantity of MAP in this amount of faeces regarding their origin of 
contamination. The quantity of MAP contamination by faecal contamination may also be 
related with the proportion animals of different risk groups that are slaughter together, 
because the existence or absence of a large proportion of highly shedders or highly 
contaminated animals in the slaughter line will influence the quantity of MAP in faeces that 
may contaminate muscle tissues. 
Depending on the objectives of the risk assessment and of the scope of the risk question, the 
units to each parameter should be assigned. For example, the evaluation of each probability 
and MAP quantity could be made per kilogram of muscle tissue at the end of the slaughter 
line. 
As an example, the final probability for MAP occurrence on muscle MAP test negative from 
infected cows older than 2 years, with clinical signs that have been accepted in the ante 
mortem inspection, with gross lesions that have been accepted in the post mortem 
inspection, characterized as being from the Red risk group, from an infected and test positive 
dairy herd in the ParaTB programme is the product between: 
 proportion of herds in the ParaTB programme; 
 proportion of dairy herds; 
 the probability of the herd be MAP infected; 
 the herd sensitivity of the test; 
 the probability of the animal be MAP infected; 
 proportion of animals older than 2 years; 
 the sensitivity of the test used; 
 the proportion of cows in the Red risk group; 
 proportion of animals with clinical signs; 
 proportion of animals with clinical signs accepted at the ante mortem inspection; 
 proportion of carcasses with observable gross lesions; 
 proportion of carcasses with observable gross lesions accepted at the post mortem 
inspection; 
 probability of MAP occurrence on muscle tissues from animals with the mentioned 
characteristics; 
 (1 – sensitivity) of the test used. 
In this scenario the final risk would also consider the quantity of MAP occurrence in muscle 





As shown in this dissertation a risk assessment conceptual model was required in order to 
assess the current knowledge on this topic. This was made in the framework of the Danish 
Paratuberculosis control programme despite Paratuberculosis has not yet been declared as 
a zoonosis. 
 
An exhaustive literature search was made to assess one point of the risk model pathway – 
MAP distribution on tissues. MAP presence on muscle by tissue culture was only 
investigated by two studies; in milk by ten studies. Most of the studies focused their attention 
on the gastro-intestinal tract. However MAP was isolated on several other tissues. Besides 
MAP isolation sites, scarce information exists about the mechanisms of MAP dissemination 
on tissues, when this dissemination occurs and its relation with other parameters as serum 
and milk antibodies, cellular immune response, MAP excretion on milk and faeces, gross and 
histopathologic lesions and clinical signs. 
From our study a merely indicative overall prevalence of MAP tissue contamination was 
assessed as 10.2% [9.8% - 10.6%], a milk prevalence of 4.7% [3.9% – 5.7%] and muscle 
prevalence of 4.8% [2.4% - 9.2%]. These results could not be used as the likelihood MAP 
occurrence in these tissues due to the results limitations discussed previously. 
 
Risk assessment is a tool that enables the analysis of a problem in a systematic, transparent 
and reliable way. In order to assess the probability and the quantity of MAP occurrence on 
muscle and milk all the pathways that may lead to MAP presence on the milk at herd level or 
on muscle tissues at the end of the slaughter line should be considered. In this work, a risk 
model pathway to analyze MAP occurrence on unprocessed beef and milk is proposed. 
When assembling the necessary data for risk evaluation, knowledge gaps concerning MAP 
distribution on milk and beef were found. 
Without the understanding of the relation between MAP probability/quantity and specific 
characteristics of different risk groups, the risk cannot be assessed properly. Therefore 
measures to reduce risk cannot be taken on specific animals or at specific points of the 
process.  
The main limitations and drawbacks of proposed risk model pathways are: 
 Lack of detailed information for herds not in the ParaTB Programme; 
 Current difficulty in certifying Herds, Animals or Milk/Muscle “Not MAP Infected” due 
to available diagnostic tools; 




 Lack of information regarding the relation between MAP occurrence in muscle and 
animal infection stage, age risk groups, existence/absence of clinical signs and 
clinical signs that may lead to ante mortem animal rejection, existence/absence of 
observable gross lesions in clinical/non clinical animals and gross lesions that may 
lead to post mortem carcass rejection. 
 
Regarding the risk model pathways, MAP contamination by faeces was out of the scope of 
the work. However, it is an aspect that should not be neglected. The impact of each source 
of MAP occurrence on unprocessed beef and milk (lymphatic/bacteraemia/faecal) should 
also be evaluated to implement specific mitigation measures. 
 
The characterization of the occurrence and the quantity of MAP in tissues and the 
assessment of the probability/quantity of MAP occurrence on beef and milk may have an 
extensive range of applications such as: 
 Indication of the best sample sites to detect MAP infection by tissue culture; 
 Evaluation of the impact that specific food processes have on MAP survival (freezing, 
pasteurization, cooking); 
 Recommendations to meat inspectors to reject/approve animals/carcasses to assure 
food safety; 
 Recommendations to farmers regarding milk collection from high risk animals, milk 
hygiene and herd management to reduce the risk of MAP occurrence on animal 
products; 
 Recommendations to industry about the use of high and low risk animal products in 
human food; 
 Recommendations to Veterinary Authorities regarding possible changes in animal 
health programmes considering the perspective of MAP infection as a possible 
hazard to food safety. 
 
In conclusion, a list of studies, where MAP was isolated by tissue culture, is available in this 
dissertation and may be useful to other authors looking for this gathered information. Some 
current knowledge gaps and lacks of information were pointed out. Regarding the risk 
assessment a detailed list of data necessary to make possible the evaluation of MAP 
sources to consumers is provided by this study. Milk and beef risk model pathways have also 
been developed and may serve risk assessors with a basis for their work.  
Further studies would be interesting to make available the mentioned knowledge gaps and to 
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6.1 Annex 1 - Tissue culture results recorded from the reviewed studies. 
 
Annex 1 – Tissue culture results recorded from the reviewed studies as well as the clinical status, husbandry type and age range of the studied 
animals. The results are grouped by tissue sampled and by reference alphabetic order. Summaries from each tissue were made. The prevalence and 








                                                
18 Sum. – Summary; Nd – No data; cont. – continuation; Husb. – Husbandry; Muc. – Mucosa; Af – Affected animals; As – Asymptomatic animals; B – Beef; D – Dairy; LN – Lymph node; Prev. – Prevalence; 
95% CI – 95% Confidence interval; <2y – younger than 2 years old; ≥2y – with or older than 2 years old; GI – Gastro-intestinal; Gl. – gland; Sup.Mam. – Supramammary; Mam.gl. – Mammary gland; In the 




  Annex 1.1 
Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Abomasum muc. 2 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
2 7 Both D ≥2y (Taylor, 1953)
Sum. Abomasum muc. 4 44       9.1% 3.6% 21.2%
Pylorus muc. 6 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 8 As D <2y (Payne & Rankin, 1961a)
Sum. Pylorus muc. 6 37       16.2% 7.7% 31.1%  
Duodenum muc. 3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 15 Both D ≥2y (Huda & Jensen, 2003)
0 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
6 21 As D <2y (Payne & Rankin, 1961b)
1 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
3 3 Both D <2y (Rankin, 1958)
1 3 Both D ≥2y (Rankin, 1958)
1 5 As D ≥2y (Rankin, 1961a)
5 9 Both D ≥2y (Rankin, 1961b)
Sum. Duodenum muc. 20 115       17.4% 11.5% 25.3%  
Jejunum muc. 3 5 Both B ≥2y (Alonso-Hearn et al., 2009)
 18 42 Both D ≥2y (Alonso-Hearn et al., 2009)
 16 40 Af D ≥2y (Antognoli et al., 2008)
 3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
 2 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
 4 15 Both D ≥2y (Huda & Jensen, 2003)
 1 1 Af D ≥2y (Larsen et al., 1981)
 2 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
 4 21 As D <2y (Payne & Rankin, 1961b)
 0 8 As D ≥2y (Payne & Rankin, 1961a)
 1 8 As D <2y (Payne & Rankin, 1961a)




Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Ileum muc. 18 40 Af D ≥2y (Antognoli et al., 2008)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
18 20 Both Nd Nd (Brady et al., 2008)
3 100 As D ≥2y (Chiodini & Vankruiningen, 1986)
6 15 Both D ≥2y (Huda & Jensen, 2003)
1 1 Af D ≥2y (Larsen et al., 1981)
6 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
85 984 As D ≥2y (McKenna et al., 2004)
4 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
3 3 Both D <2y (Rankin, 1958)
  1 3 Both D ≥2y    (Rankin, 1958)
1 5 As D ≥2y (Rankin, 1961a)
 7 9 Both D ≥2y (Rankin, 1961b)
 4 12 As B <2y (Stabel, Palmer & Whitlock, 2003)
Sum. Ileum muc. 160 1272       12.6% 10.9% 14.5%  
Cecum muc. 3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
 5 15 Both D ≥2y (Huda & Jensen, 2003)
 1 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
 6 21 As D <2y (Payne & Rankin, 1961b)
 0 8 As D ≥2y (Payne & Rankin, 1961a)
 0 8 As D <2y (Payne & Rankin, 1961a)
 3 3 Both D <2y (Rankin, 1958)
  2 3 Both D ≥2y    (Rankin, 1958)
 1 5 As D ≥2y (Rankin, 1961a)
 6 9 Both D ≥2y (Rankin, 1961b)
 13 16 As D ≥2y (Whitlock et al., 1997)








Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Ileo-cecal valve muc. 2 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
5 100 As D ≥2y (Chiodini & Vankruiningen, 1986)
4 15 Both D ≥2y (Huda & Jensen, 2003)
4 7 Af D ≥2y (Koenig et al., 1993)
58 148 Both D ≥2y (Kopecky, Larsen & Merkal, 1967)
5 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
10 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
1 12 As B <2y (Stabel, Palmer & Whitlock, 2003)
27 35 As D ≥2y (Whitlock et al., 1997)
Sum. Ileo-cecal valve muc. 119 397       30.0% 25.7% 34.7%  
Colon muc. 2 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
 8 21 As D <2y (Payne & Rankin, 1961b)
 0 8 As D ≥2y (Payne & Rankin, 1961a)
 1 8 As D <2y (Payne & Rankin, 1961a)
 8 12 As B <2y (Stabel, Palmer & Whitlock, 2003)
 13 18 As D ≥2y (Whitlock et al., 1997)
Sum. Colon muc. 32 96       33.3% 24.7% 43.2%  
Rectum muc. 4 15 Both D ≥2y (Huda & Jensen, 2003)
 0 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
 3 21 As D <2y (Payne & Rankin, 1961b)
 1 8 As D <2y (Payne & Rankin, 1961a)
 0 8 As D ≥2y (Payne & Rankin, 1961a)
 1 3 Both D ≥2y (Rankin, 1958)
 3 3 Both D <2y (Rankin, 1958)
 1 5 As D ≥2y (Rankin, 1961a)
 5 8 Both D ≥2y (Rankin, 1961b)








Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference 
Ileum + Cecum muc. 13 20 Af D <2y 65.0% 43.3% 81.9% (Thorel, Pardon, Irgens, Marly & Lechopier, 1984) 
Ileum + Ileocecal-valve muc. 5 5 Both B ≥2y (Alonso-Hearn et al., 2009) 
19 42 Both D ≥2y (Alonso-Hearn et al., 2009) 
Small Intestine 15 19 Both Nd Nd (Brady et al., 2008) 
3 5 As D <2y (Larsen et al., 1975) 
1 3 As D ≥2y (Larsen et al., 1975) 
4 4 As D <2y (Saxegaard, 1990) 
19 23 Both D ≥2y (Taylor, 1953) 
Large Intestine 13 20 Both Nd Nd (Brady et al., 2008) 
13 21 Both D ≥2y (Taylor, 1953) 
Intestinal Mucosa 26 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965) 





Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference 
Duodenal LN 0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004) 
3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004) 
1 15 Both D ≥2y (Huda & Jensen, 2003) 
Sum. Duodenal LN 4 29 13.8% 5.5% 30.6%   
Jejunal LN 4 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004) 
3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004) 
5 15 Both D ≥2y (Huda & Jensen, 2003) 
1 1 Af D ≥2y (Larsen et al., 1981) 
Sum. Jejunal LN 13 30 43.3% 27.4% 60.8%   
Jejunal Peyer's Patches 5 18 As D <2y 27.8% 12.5% 50.9% (Beard et al., 2001) 
Ileal LN 0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004) 
3 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004) 
4 15 Both D ≥2y (Huda & Jensen, 2003) 
1 1 Af D ≥2y (Larsen et al., 1981) 
6 12 As B <2y (Stabel, Palmer & Whitlock, 2003) 






Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Ileocecal LN 17 40 Af D ≥2y (Antognoli et al., 2008)
16 18 Both Nd Nd (Brady et al., 2008)
3 15 Both D ≥2y (Huda & Jensen, 2003)
2 448 As D <2y (Jorgensen, 1965)
15 662 As D ≥2y (Jorgensen, 1965)
5 6 Both D ≥2y (Koenig et al., 1993)
0 29 As D ≥2y (McDonald, Ridge, Hope & Condron, 1999)
  110 984 As D ≥2y    (McKenna et al., 2004)
11 1191 As Both ≥2y (Merkal, Whipple, Sacks & Snyder, 1987)
81 2827 As D ≥2y (Merkal, Whipple, Sacks & Snyder, 1987)
27 3522 As B ≥2y (Merkal, Whipple, Sacks & Snyder, 1987)
12 21 As D <2y (Payne & Rankin, 1961b)
5 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
2 3 Both D <2y (Rankin, 1958)
2 3 Both D ≥2y (Rankin, 1958)
3 5 As D ≥2y (Rankin, 1961a)
8 9 Both D ≥2y (Rankin, 1961b)
9 350 Af B ≥2y (Rossiter & Henning, 2001)
65 189 Af D ≥2y (Rossiter & Henning, 2001)
34 407 Both D ≥2y (Seitz et al., 1989)
9 12 As B <2y (Stabel, Palmer & Whitlock, 2003)
Sum. Ileocecal LN 436 10757       4.1% 3.7% 4.4%  
Cecal LN 8 100 As D ≥2y 8.0% 4.1% 15.0% (Chiodini & Vankruiningen, 1986)






Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference 
Mesenteric LN 16 40 Af D ≥2y (Antognoli et al., 2008) 
8 18 As D <2y (Beard et al., 2001) 
16 20 Both Nd Nd (Brady et al., 2008) 
14 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965) 
3 5 As D <2y (Larsen et al., 1975) 
1 3 As D ≥2y (Larsen et al., 1975) 
11 21 As D <2y (Payne & Rankin, 1961b) 
5 8 As D <2y (Payne & Rankin, 1961a) 
  0 8 As D ≥2y    (Payne & Rankin, 1961a) 
2 3 Both D ≥2y (Rankin, 1958) 
2 3 Both D <2y (Rankin, 1958) 
1 5 As D ≥2y (Rankin, 1961a) 
6 9 Both D ≥2y (Rankin, 1961b) 
4 4 As D <2y (Saxegaard, 1990) 
51 400 As Both ≥2y (Smith, 1954) 
20 23 Both D ≥2y (Taylor, 1953) 
21 21 Af D <2y (Thorel, Pardon, Irgens, Marly & Lechopier, 1984) 
Sum. Mesenteric LN 181 617 29.3% 25.9% 33.0%   
Ileocecal + Jejunal LN 4 5 Both B ≥2y (Alonso-Hearn et al., 2009) 
  19 42 Both D ≥2y (Alonso-Hearn et al., 2009) 
Sum. GI Lymphoid Tissue 692 11652 5.9% 5.5% 6.4%   
Duodenum + LN 5 12 As B <2y (Stabel, Palmer & Whitlock, 2003) 
Jejunum + LN 8 12 As B <2y (Stabel, Palmer & Whitlock, 2003) 
Ileum muc + Ileocecal LN 22 400 As Both ≥2y (McNab, Meek, Duncan, Martin & Vandreumel, 1991) 
GI tract 198 497 As D ≥2y (Pavlik et al., 2000) 
9 45 As B ≥2y (Pavlik et al., 2000) 
11 69 As Both ≥2y (Pavlik et al., 2000) 







Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Mandibular LN 1 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
5 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
Sum. Mandibular LN 6 51 11.8% 5.5% 23.4%  
Submaxilar LN 3 3 Both D <2y (Rankin, 1958)
0 2 Both D ≥2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
4 8 Both D ≥2y (Rankin, 1961b)
11 23 Both D ≥2y (Taylor, 1953)
Sum. Submaxilar LN 18 41 43.9% 29.9% 59.0%  
Parotid LN 0 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 8 As D <2y (Payne & Rankin, 1961a)
Sum. Parotid LN 0 37 0.0% 0.0% 9.4%  
Suprapharyngeal LN 12 21 As D <2y (Payne & Rankin, 1961b)
6 8 As D <2y (Payne & Rankin, 1961a)
1 8 As D ≥2y (Payne & Rankin, 1961a)
Sum. Suprapharyngeal LN 19 37 51.4% 35.9% 66.6%  
Retropharyngeal LN 4 40 Af D ≥2y (Antognoli et al., 2008)
0 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
0 15 Both D ≥2y (Huda & Jensen, 2003)
1 2 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
3 5 As D ≥2y (Rankin, 1961a)
8 8 Both D ≥2y (Rankin, 1961b)
15 23 Both D ≥2y (Taylor, 1953)





Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Tonsil 2 100 As D ≥2y (Chiodini & Vankruiningen, 1986)
0 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
0 15 Both D ≥2y (Huda & Jensen, 2003)
10 21 As D <2y (Payne & Rankin, 1961b)
2 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
Sum. Tonsil 14 178 7.9% 4.7% 12.8%  
Head LN 11 18 Both Nd Nd (Brady et al., 2008)
16 22 As D ≥2y (Whitlock et al., 1997)
Sum. Head Lymphoid tissue 118 506 23.3% 19.8% 27.2%  
Bronchial LN 0 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
Sum. Bronchial LN 0 37 0.0% 0.0% 9.4%  
Mediastinal LN 1 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
0 15 Both D ≥2y (Huda & Jensen, 2003)
1 1 Af D ≥2y (Larsen et al., 1981)
2 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
3 3 Both D <2y (Rankin, 1958)
0 2 Both D ≥2y (Rankin, 1958)
1 5 As D ≥2y (Rankin, 1961a)
5 8 Both D ≥2y (Rankin, 1961b)
15 23 Both D ≥2y (Taylor, 1953)
Sum. Mediastinal LN 28 134 20.9% 14.9% 28.5%  
Pulmonary LN 32 82 As D ≥2y 39.0% 29.2% 49.8% (Whitlock et al., 1997)
Superficial Cervical LN 6 189 Af D ≥2y (Rossiter & Henning, 2001)
1 350 Af B ≥2y (Rossiter & Henning, 2001)






Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Hepatic LN 17 40 Af D ≥2y (Antognoli et al., 2008)
1 15 Both D ≥2y (Huda & Jensen, 2003)
8 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
1 8 As D <2y (Payne & Rankin, 1961a)
1 1 Both D ≥2y (Rankin, 1958)
1 5 As D ≥2y (Rankin, 1961a)
6 8 Both D ≥2y (Rankin, 1961b)
2 12 As B <2y (Stabel, Palmer & Whitlock, 2003)
16 23 Both D ≥2y (Taylor, 1953)
41 80 As D ≥2y (Whitlock et al., 1997)
Sum. Hepatic LN 94 221 42.5% 36.2% 49.1%  
Iliac LN 2 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 2 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
3 8 Both D ≥2y (Rankin, 1961b)
2 12 As B <2y (Stabel, Palmer & Whitlock, 2003)
1 2 Both D ≥2y (Taylor, 1953)
Sum. Iliac LN 11 69 15.9% 9.1% 26.3%  
Popliteal LN 3 40 Af D ≥2y (Antognoli et al., 2008)
0 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
4 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 2 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
2 8 Both D ≥2y (Rankin, 1961b)
1 350 Af B ≥2y (Rossiter & Henning, 2001)
6 189 Af D ≥2y (Rossiter & Henning, 2001)





Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Precrural LN 6 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 8 As D <2y (Payne & Rankin, 1961a)
Sum. Precrural LN 6 37       16.2% 7.7% 31.1%  
Prescapular LN 1 40 Af D ≥2y (Antognoli et al., 2008)
0 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
5 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
  0 8 As D <2y    (Payne & Rankin, 1961a)
Prescapular LN (cont.) 0 2 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
3 8 Both D ≥2y (Rankin, 1961b)
6 6 Both D ≥2y (Taylor, 1953)
Sum. Prescapular LN 18 127       14.2% 9.2% 21.3%  
Supramammary LN 6 40 Af D ≥2y (Antognoli et al., 2008)
0 34 Af D ≥2y (Doyle, 1954)
0 15 Both D ≥2y (Huda & Jensen, 2003)
0 2 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
1 5 As D ≥2y (Rankin, 1961a)
3 7 Both D ≥2y (Rankin, 1961b)
22 81 As D ≥2y (Sweeney et al., 1992b)
1 4 Af D ≥2y (Taylor et al., 1981)
16 60 As D ≥2y (Whitlock et al., 1997)
Sum. Supramammary LN 52 251       20.7% 16.2% 26.2%  
Prescapular and Popliteal LN 13 19 Both Nd Nd (Brady et al., 2008)
Sum. Other LN 398 2682       14.8% 13.5% 16.2%  








Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Kidney 6 40 Af D ≥2y (Antognoli et al., 2008)
1 1 Af D ≥2y (Hines et al., 1987)
0 1 Af D ≥2y (Larsen et al., 1981)
1 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 8 As D <2y (Payne & Rankin, 1961a)
0 3 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
2 8 Both D ≥2y (Rankin, 1961b)
Sum. Kidney 13 98 13.3% 7.9% 21.4%  
Liver 10 40 Af D ≥2y (Antognoli et al., 2008)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
2 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
2 100 As D ≥2y (Chiodini & Vankruiningen, 1986)
0 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
0 1 Af D ≥2y (Larsen et al., 1981)
3 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 3 Both D ≥2y (Rankin, 1958)
  3 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
3 8 Both D ≥2y (Rankin, 1961b)
15 189 Af D ≥2y (Rossiter & Henning, 2001)
1 350 Af B ≥2y (Rossiter & Henning, 2001)
15 22 Both D ≥2y (Taylor, 1953)








Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Lung 4 40 Af D ≥2y (Antognoli et al., 2008)
1 1 Af D ≥2y (Larsen et al., 1981)
1 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 8 As D <2y (Payne & Rankin, 1961a)
0 3 Both D ≥2y (Rankin, 1958)
2 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
2 8 Both D ≥2y (Rankin, 1961b)
10 22 Both D ≥2y (Taylor, 1953)
Sum. Lung 20 119       16.8% 11.2% 24.5%  
Spleen 1 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
1 26 As D <2y (Gilmour, Nisbet & Brotherston, 1965)
1 1 Af D ≥2y (Larsen et al., 1981)
4 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D ≥2y (Payne & Rankin, 1961a)
0 8 As D <2y (Payne & Rankin, 1961a)
0 3 Both D ≥2y (Rankin, 1958)
3 3 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
1 8 Both D ≥2y (Rankin, 1961b)
6 21 Both D ≥2y (Taylor, 1953)
15 83 As D ≥2y (Whitlock et al., 1997)













Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Bulbourethral gl. 0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 3 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
2 4 Af Both ≥2y (Larsen & Kopecky, 1970)
Sum. Bulbourethral gl. 2 17 11.8% 3.3% 34.3%  
Epididymis 2 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
Sum. Epididymis 2 14 14.3% 4.0% 39.9%  
Ovaries 1 4 Af D ≥2y (Lawrence, 1956)
1 3 Both D ≥2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
3 6 Both D ≥2y (Rankin, 1961b)
Sum. Ovaries 5 18 27.8% 12.5% 50.9%  
Prostate 1 1 Af D ≥2y (Larsen et al., 1981)
3 6 Af Both ≥2y (Larsen & Kopecky, 1970)
Sum. Prostate 4 7 57.1% 25.0% 84.2%  
Seminal vesicles 2 3 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
6 6 Af Both ≥2y (Larsen & Kopecky, 1970)
1 1 Af D ≥2y (Larsen et al., 1981)
Sum. Seminal vesicles 9 20 45.0% 25.8% 65.8%  
Testes 0 10 As D <2y (Ayele, Bartos, Svastova & Pavlik, 2004)
2 4 As D ≥2y (Ayele, Bartos, Svastova & Pavlik, 2004)
0 6 Af Both ≥2y (Larsen & Kopecky, 1970)
0 1 Af D ≥2y (Larsen et al., 1981)
1 1 Af D ≥2y (Lawrence, 1956)
Sum. Testes 3 22 13.6% 4.7% 33.3%  
Uterus 18 148 Both D ≥2y (Kopecky, Larsen & Merkal, 1967)
1 3 Both D ≥2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
5 7 Both D ≥2y (Rankin, 1961b)
Sum. Uterus 24 163 14.7% 10.1% 21.0%  
Bladder 0 7 Both D ≥2y (Rankin, 1961b)
1 5 As D ≥2y (Rankin, 1961a)







Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Fetus 9 24 NA NA NA (Doyle, 1958)
2 2 Af D ≥2y (Koenig et al., 1993)
5 24 Af D NA (Lawrence, 1956)
9 407 Both D ≥2y (Seitz et al., 1989)
5 58 As D ≥2y (Sweeney et al., 1992b)
Sum. Fetus 30 515 5.8% 4.1% 8.2%  
Mammary Gland 4 4 Af D ≥2y (Alexejeff-Goloff, 1929)
2 34 Af D ≥2y (Doyle, 1954)
1 1 Both D ≥2y (Rankin, 1958)
0 2 Both D <2y (Rankin, 1958)
0 5 As D ≥2y (Rankin, 1961a)
2 6 Both D ≥2y (Rankin, 1961b)
2 4 Af D ≥2y (Taylor et al., 1981)
Sum. Mammary Gland 11 56 19.6% 11.3% 31.8%  
Diaphragm muscle 2 5 Both B ≥2y (Alonso-Hearn et al., 2009)
4 42 Both D ≥2y (Alonso-Hearn et al., 2009)
Muscle extensor carpi radialis 0 40 Af D ≥2y (Antognoli et al., 2008)
Heart muscle 2 40 Af D ≥2y (Antognoli et al., 2008)
Muscle longissimus colli 0 40 Af D ≥2y (Antognoli et al., 2008)
Sum. Muscle 8 167 4.8% 2.4% 9.2%  
Pharynx 4 21 As D <2y (Payne & Rankin, 1961b)
0 8 As D <2y (Payne & Rankin, 1961a)
0 8 As D ≥2y (Payne & Rankin, 1961a)






Tissue sampled Positives Samples collected Clinical Status Husb. Type Age range Prev. 95% CI Reference
Sup.Mam. LN and Mam.gl. 8 16 Both Nd Nd (Brady et al., 2008)
Abdominal organs 8 18 Both Nd Nd    (Brady et al., 2008)
Thoracic organs 14 21 Both Nd Nd (Brady et al., 2008)
Plasma 1 7 Af D ≥2y 14.3% 2.6% 51.3% (Koenig et al., 1993)
Colostrum 10 126 As D Nd 7.9% 4.4% 14.0% (Streeter et al., 1995)
Semen 1 1 As D ≥2y    (Ayele, Bartos, Svastova & Pavlik, 2004)
1 1 Af Both ≥2y (Larsen & Kopecky, 1970)
1 1 Af D ≥2y (Larsen et al., 1981)
Sum. Semen 3 3 100.0% 43.8% 100.0%  
Milk 3 4 Af D ≥2y (Alexejeff-Goloff, 1929)
15 86 As D Nd (Ayele et al., 2005)
5 11 Af D ≥2y (Giese & Ahrens, 2000)
43 1493 As D Nd (Jayarao et al., 2004)
2 24 As D Nd (Paolicchi et al., 2003)
9 211 As D Nd (Pillai & Jayarao, 2002)
1 20 Af D ≥2y (Smith, 1960)
0 13 As D Nd (Smith, 1960)
3 126 As D Nd (Streeter et al., 1995)
9 77 As D ≥2y (Sweeney et al., 1992b)
9 26 Af D ≥2y (Taylor et al., 1981)
Sum. Milk 99 2091 4.7% 3.9% 5.7%  
Collection chamber flush fluid 2 6 Af D ≥2y 33.3% 9.7% 70.0% (Koenig et al., 1993)
Uterine flush fluid 3 4 Af D ≥2y 75.0% 30.1% 95.4% (Rohde & Shulaw, 1990)
Mammary Gland flush fluid 0 7 Af D ≥2y 0.0% 0.0% 35.4% (Koenig et al., 1993)
Sum. All tissues analyzed 2297 22485 10.2% 9.8% 10.6%  
 
 
